cerebrovascular disorder: A disorder resulting from inadequate blood flow in the vessels that supply the brain. Representative examples include cerebrovascular ischemia, cerebral embolism, and cerebral infarction.
Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere
DOID EFO Endpoint Browser PheWeb
I9_CEREBDOTH
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519870 |
1. Apply sex-specific ruleNone |
519870 |
2. Check conditionsNone |
519870 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
3058 |
4. Check minimum number of eventsNone |
3058 |
5. Include endpointsNone |
3058 |
6. Filter based on genotype QC (FinnGen only) |
2962 |
Control definitions (FinnGen only)
- Control exclude
- I9_CEREBVASC
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
Similar endpoints
↥List of similar endpoints to
Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere
based on the number of shared cases.
Similar with more cases:
- Cerebrovascular diseases
- Neurological diseases, wide definition
- Cardiovascular diseases
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 35100 | 17373 | 17089 |
| Only index persons | 20088 | 10110 | 9978 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.49 | 0.50 | 0.48 |
| Only index persons | 0.38 | 0.37 | 0.38 |
| Median age at first event (years) | |||
| Whole population | 72.53 | 75.26 | 69.77 |
| Only index persons | 69.92 | 72.84 | 66.95 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 2962 | 1339 | 1623 |
| Unadjusted period prevalence (%) | 0.62 | 0.48 | 0.74 |
| Median age at first event (years) | 68.36 | 67.82 | 68.81 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 3055
- Matched controls
- 30487
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
B01AC04
ATC
clopidogrel; oral
4.5
317.0
1065
3245
I63.3
ICD-10 Finland
Cerebral infarction due to thrombosis of cerebral arteries
993.5
307.7
429
5
G46.4*I67.9
ICD-10 Finland
Cerebellar stroke syndrome
+∞
307.7
680
*
G46.3*I67.9
ICD-10 Finland
Brain stem stroke syndrome (I60-I67+)
+∞
307.7
473
*
I67.8
ICD-10 Finland
Other specified cerebrovascular diseases
967.7
307.7
490
6
I67.9
ICD-10 Finland
Cerebrovascular disease, unspecified
1413.1
307.7
1149
13
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
234.9
307.7
1072
70
AA1AD
NOMESCO Finland
CT of head and brain
4.6
307.7
1566
5703
K90
ICPC
Stroke/cerebrovascular accident
38.5
307.7
284
81
G46.8*I67.9
ICD-10 Finland
Other vascular syndromes of brain in cerebrovascular diseases
185.2
307.7
175
10
B01AC30
ATC
platelet aggregation inhibitors excl. heparin - combinations
15.7
307.7
696
561
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
372.5
307.7
1174
51
PA6BD
NOMESCO Finland
Extensive CT of neck arteries
11.5
287.6
311
297
G45.9
ICD-10 Finland
Transient cerebral ischaemic attack, unspecified
5.8
272.4
571
1166
AA5BD
NOMESCO Finland
CT of cerebral ischaemia
20.8
236.3
181
92
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
5.4
217.8
482
1024
XA800
NOMESCO Finland
Neuropsychological investigation
10.2
215.4
251
265
B01AC07
ATC
dipyridamole; systemic
5.8
210.0
424
828
I63.4
ICD-10 Finland
Cerebral infarction due to embolism of cerebral arteries
2019.8
208.5
200
*
4360A
ICD-9 Finland
Acute but ill-defined cerebrovascular disease[MORBUS CEREBROVASCULARIS ACUTUS NON DEFINITUS]
+∞
171.4
163
*
R42
ICD-10 Finland
Dizziness and giddiness
2.9
166.0
1111
4954
K91
ICPC
Cerebrovascular disease
23.3
161.0
117
52
G46.7*I67.9
ICD-10 Finland
Other lacunar syndromes
+∞
159.7
152
*
I67.3
ICD-10 Finland
Progressive vascular leukoencephalopathy
17.9
139.7
114
66
I63.0
ICD-10 Finland
Cerebral infarction due to thrombosis of precerebral arteries
+∞
133.2
127
*
G45.0
ICD-10 Finland
Vertebro-basilar artery syndrome
7.2
132.8
205
303
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.7
132.2
955
4346
PA6AD
NOMESCO Finland
CT of neck arteries
6.8
122.6
199
310
PA6DE
NOMESCO Finland
Neck artery ultrasound examination with Doppler method
5.4
120.3
250
495
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
4.1
115.5
350
939
I63
ICD-10 Finland
Cerebral infarction
64.2
113.8
63
10
R4120
NOMESCO Finland
Occupational therapy
4.6
112.0
281
652
N18
ICPC
Paralysis/weakness
10.9
111.2
121
115
R51.80
ICD-10 Finland
Headache
3.1
109.9
540
1977
I67.1
ICD-10 Finland
Cerebral aneurysm, nonruptured
373.0
109.0
109
*
PAF14
NOMESCO Finland
Thrombendarterectomy of internal carotid artery
55.5
105.6
60
11
C10AA05
ATC
atorvastatin; oral
2.3
104.0
1567
9693
G46.4
ICD-10 Finland
Cerebellar stroke syndrome
266.2
101.3
103
*
I63.5
ICD-10 Finland
Cerebral infarction due to unspecified occlusion or stenosis of cerebral arteries
257.9
98.2
100
*
PA2CC
NOMESCO Finland
Cerebral very extensive angiography with X-ray
45.4
97.8
58
13
315
Kela drug reimbursment
Clopidogrel
11.7
97.5
101
89
G45.1
ICD-10 Finland
Carotid artery syndrome (hemispheric)
5.3
95.7
199
393
I63.8
ICD-10 Finland
Other cerebral infarction
322.8
94.4
95
*
PA7AD
NOMESCO Finland
CT angiography of head and neck vasculature
5.5
93.3
187
357
4340A
ICD-9 Finland
Occlusion of cerebral arteries, Cerebral thrombosis
+∞
90.0
86
*
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
2.8
89.8
512
2020
I65.2
ICD-10 Finland
Occlusion and stenosis of carotid artery
105.2
84.3
92
9
PA2BC
NOMESCO Finland
Cerebral extensive angiography with X-ray
37.7
83.8
52
14
I63.1
ICD-10 Finland
Cerebral infarction due to embolism of precerebral arteries
+∞
81.6
78
*
I69.8
ICD-10 Finland
Sequelae of other and unspecified cerebrovascular diseases
41.4
80.8
49
12
I69.1
ICD-10 Finland
Sequelae of intracerebral haemorrhage
270.4
77.8
79
*
PA2BD
NOMESCO Finland
Extensive CT angiography of brain
12.3
76.2
76
63
G81.9
ICD-10 Finland
Hemiplegia, unspecified
13.4
75.8
72
55
B01AA03
ATC
warfarin; systemic
2.2
75.6
928
5139
G46.3
ICD-10 Finland
Brain stem stroke syndrome
+∞
75.3
72
*
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
4.1
74.6
215
552
C10AA01
ATC
simvastatin; oral
2.0
72.8
1608
10961
I63.2
ICD-10 Finland
Cerebral infarction due to unspecified occlusion or stenosis of precerebral arteries
+∞
72.1
69
*
PA2AD
NOMESCO Finland
CT angiography of brain
16.5
71.0
60
37
43899
ICD-8 Finland
Other and ill-defined cerebrovascular disease, Without mention of hypertension
+∞
69.0
66
*
I61.9
ICD-10 Finland
Intracerebral haemorrhage, unspecified
124.4
68.1
73
6
F01.9
ICD-10 Finland
Vascular dementia, unspecified
5.7
66.5
126
228
I61.0
ICD-10 Finland
Intracerebral haemorrhage in hemisphere, subcortical
650.5
65.1
64
*
4380A
ICD-9 Finland
Late effects of cerebrovascular disease[SEQUELAE MORBI CEREBROVASCULARIS]
+∞
64.8
62
*
R53
ICD-10 Finland
Malaise and fatigue
2.0
64.4
894
5132
H53.4
ICD-10 Finland
Visual field defects
6.6
64.2
104
161
AA5PD
NOMESCO Finland
CT examination of brain pefusion
20.3
62.5
48
24
Z2445
NOMESCO Finland
Psychologist
5.4
62.4
125
238
R4150
NOMESCO Finland
Neuropsychological rehabilitation
26.5
60.7
42
16
PA7CD
NOMESCO Finland
CT angiography of neck and brain, extensive
12.0
57.4
58
49
I60.9
ICD-10 Finland
Subarachnoid haemorrhage, unspecified
+∞
56.4
54
*
I10
ICD-10 Finland
Essential (primary) hypertension
1.9
54.8
2101
16446
G40.9
ICD-10 Finland
Epilepsy, unspecified
4.4
54.3
141
334
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
2.8
54.2
306
1186
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.0
50.7
629
3426
AAL10
NOMESCO Finland
Intracranial endovascular thrombolysis
505.1
50.5
50
*
N03AX14
ATC
levetiracetam; systemic
4.9
49.3
111
234
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.8
49.1
1133
7541
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
2.7
49.0
286
1126
AAC00
NOMESCO Finland
Ligature of intracranial aneurysm
+∞
48.0
46
*
XF400
NOMESCO Finland
ECG with 12 standard connections
2.0
47.9
591
3206
AAF00
NOMESCO Finland
Ventriculostomy
17.4
46.2
38
22
C09AA05
ATC
ramipril; oral
1.8
46.0
946
6058
R4130
NOMESCO Finland
Speech therapy
4.9
45.8
102
213
N03AF02
ATC
oxcarbazepine; oral
4.4
45.7
118
278
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
2.6
45.3
282
1145
G46.5*I67.9
ICD-10 Finland
Pure motor lacunar syndrome
453.4
45.3
45
*
AA1BM
NOMESCO Finland
MRI examination of brain with 3 Tesla magnet
8.9
44.8
56
64
TAB00
NOMESCO Finland
Lumbar puncture
3.5
44.0
154
451
C08CA01
ATC
amlodipine; oral
1.7
44.0
1342
9584
205
Kela drug reimbursment
Chronic hypertension
1.7
43.9
1093
7378
G44.2
ICD-10 Finland
Tension-type headache
2.3
43.8
383
1813
I69.0
ICD-10 Finland
Sequelae of subarachnoid haemorrhage
119.1
43.8
47
*
G40.22
ICD-10 Finland
Complex partial epileptic seizure with secondary generalization
5.4
42.8
86
164
G40.29
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
5.5
42.8
84
157
R1230
NOMESCO Finland
Neuropsychological evaluation of need and possibilities to rehabilitation
12.1
42.7
43
36
N03AG01
ATC
valproic acid; systemic, rectal
3.0
42.4
193
664
C10AX09
ATC
ezetimibe; oral
2.0
41.7
552
3056
F01.30
ICD-10 Finland
Mixed cortical and subcortical vascular dementia without additional symptoms
12.6
40.9
40
32
G46.8
ICD-10 Finland
Other vascular syndromes of brain in cerebrovascular diseases
207.3
39.9
41
*
R1260
NOMESCO Finland
Evaluation of communicative skills
5.5
39.5
77
143
R20.2
ICD-10 Finland
Paraesthesia of skin
2.8
39.3
214
811
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.8
38.9
212
804
4378X
ICD-9 Finland
Other and ill-defined cerebrovascular disease, Other[MORBUS CERBROVASCULARIS ALIA DEFINITA]
+∞
38.6
37
*
R56.8
ICD-10 Finland
Other and unspecified convulsions
3.1
38.5
163
537
PA7BD
NOMESCO Finland
CT angiography of neck and brain
6.2
37.8
65
107
I64
ICD-10 Finland
Stroke, not specified as haemorrhage or infarction
49.5
36.6
44
9
A28
ICPC
Limited function/disability NOS
1.8
36.3
746
4722
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.0
36.1
422
2227
N19
ICPC
Speech disorder
6.7
36.0
57
86
SPAT1226
SPAT
Implementation of occupational therapy rehabilitation plan
3.9
36.0
107
280
N06AB04
ATC
citalopram; systemic
1.8
35.6
617
3710
E78.01
ICD-10 Finland
Pure hypercholesterolaemia
1.7
35.6
812
5290
Z3226
NOMESCO Finland
Physiotherapist
1.9
35.6
547
3169
H53.2
ICD-10 Finland
Diplopia
3.4
34.4
129
395
R47.0
ICD-10 Finland
Dysphasia and aphasia
8.0
34.0
46
58
WX892
NOMESCO Finland
Monitored bed care
2.3
33.4
261
1173
I67.0
ICD-10 Finland
Dissection of cerebral arteries, nonruptured
+∞
33.4
32
*
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
4.7
32.6
75
161
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
3.8
32.6
102
277
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.6
31.7
1491
11530
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.8
31.7
508
2973
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
2.0
31.6
390
2093
4019X
ICD-9 Finland
Essential hypertension, Unspecified
2.8
31.2
157
570
R4110
NOMESCO Finland
Physiotherapy
1.7
30.6
800
5368
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
5.1
30.3
64
128
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
2.3
29.8
238
1079
E78.5
ICD-10 Finland
Hyperlipidaemia, unspecified
2.0
29.8
357
1895
AA1AG
NOMESCO Finland
Short MRI examination of brain with median intensity magnet
6.1
29.7
52
87
FM1BE
NOMESCO Finland
Cardiac ultrasound examination through oesophagus
2.5
29.6
203
860
N30.0
ICD-10 Finland
Acute cystitis
1.8
28.5
519
3147
P20
ICPC
Memory disturbance
1.7
28.4
587
3691
G40.20
ICD-10 Finland
Complex partial seizures with only alteration of consciousness
7.6
28.4
40
53
G46.6*I67.9
ICD-10 Finland
Pure sensory lacunar syndrome
+∞
28.1
27
*
N05AH04
ATC
quetiapine; oral
1.8
28.1
459
2695
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.7
28.0
547
3385
C03CA01
ATC
furosemide; systemic
1.5
27.7
1271
9677
PA6AE
NOMESCO Finland
Ulrasound examination of neck vasculature
6.4
27.7
46
73
S06.0
ICD-10 Finland
Concussion
2.0
27.5
332
1765
TPH04
NOMESCO Finland
Cathetrisation of vein
1.7
27.4
673
4426
N06AB10
ATC
escitalopram; oral
1.8
27.1
461
2736
I95.1
ICD-10 Finland
Orthostatic hypotension
2.5
27.0
183
771
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.8
26.5
502
3075
A10AE04
ATC
insulin glargine; parenteral
2.0
26.3
320
1705
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
2.4
26.2
196
863
N06AX11
ATC
mirtazapine; oral
1.6
26.2
943
6788
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.7
26.2
549
3458
R47.1
ICD-10 Finland
Dysarthria and anarthria
6.1
25.9
45
75
A10AB05
ATC
insulin aspart; parenteral
2.1
25.3
251
1240
A10AC01
ATC
insulin (human); parenteral
2.0
25.3
278
1428
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.7
25.2
512
3193
I61.1
ICD-10 Finland
Intracerebral haemorrhage in hemisphere, cortical
+∞
25.0
24
*
F32.9
ICD-10 Finland
Depressive episode, unspecified
2.0
25.0
286
1491
H53.1
ICD-10 Finland
Subjective visual disturbances
2.3
24.7
197
892
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
1.8
24.7
390
2261
S06.5
ICD-10 Finland
Traumatic subdural haemorrhage
2.8
24.6
124
451
R41.0
ICD-10 Finland
Disorientation, unspecified
2.7
24.6
139
537
R55
ICD-10 Finland
Syncope and collapse
1.8
24.4
399
2336
I25.1
ICD-10 Finland
Atherosclerotic heart disease
1.5
24.1
901
6514
I25.9
ICD-10 Finland
Chronic ischaemic heart disease, unspecified
1.8
24.1
443
2684
N02BE01
ATC
paracetamol; systemic, rectal
1.7
24.1
2550
22895
G43.1
ICD-10 Finland
Migraine with aura [classical migraine]
2.6
24.1
145
578
I48
ICD-10 Finland
Atrial fibrillation and flutter
1.5
23.2
867
6259
I69
ICD-10 Finland
Sequelae of cerebrovascular disease
54.3
23.0
27
5
N03AX12
ATC
[U] gabapentin; oral
1.7
22.5
455
2827
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.7
22.4
475
2989
C01DA14
ATC
isosorbide mononitrate; oral
1.6
22.4
702
4866
SPAT1216
SPAT
Assessment of functional ability
1.6
22.2
547
3579
SPAT1229
SPAT
Assessment of need for aid
1.9
21.9
276
1485
N02AX02
ATC
tramadol; systemic, rectal
1.5
21.9
1243
9740
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.6
21.8
593
3975
XCK00
NOMESCO Finland
Perimetry
2.1
21.7
210
1027
K89
ICPC
Transient cerebral ischaemia
4.9
21.5
47
97
N03AB02
ATC
phenytoin; systemic
4.8
21.4
48
101
G45
ICD-10 Finland
Transient cerebral ischaemic attacks and related syndromes
5.9
21.3
38
65
Z01.8
ICD-10 Finland
Other specified special examinations
1.6
21.2
616
4189
N03AX16
ATC
[U] pregabalin
1.6
21.2
629
4300
R41.3
ICD-10 Finland
Other amnesia
2.6
20.9
122
479
R07.4
ICD-10 Finland
Chest pain, unspecified
1.5
20.9
844
6171
I67.2
ICD-10 Finland
Cerebral atherosclerosis
19.5
20.8
31
16
103
Kela drug reimbursment
Diabetes, insulin-treated
1.5
20.7
869
6399
J01MA02
ATC
ciprofloxacin; systemic
1.4
20.3
1176
9212
G43.9
ICD-10 Finland
Migraine, unspecified
2.7
20.2
112
429
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
1.8
20.0
318
1843
A02BC02
ATC
pantoprazole; systemic
1.4
20.0
1921
16480
C07AB07
ATC
bisoprolol; oral
1.4
20.0
1584
13125
TKC20
NOMESCO Finland
Catheterisation of bladder
2.0
19.9
240
1271
43399
ICD-8 Finland
Cerebral thrombosis, Without mention of hypertension
+∞
19.8
19
*
C10AA03
ATC
pravastatin; oral
1.9
19.7
254
1377
E11.00
ICD-10 Finland
Non-insulin dependent diabetes diabetic hypoglycaemic coma
2.4
19.6
136
579
N03AX09
ATC
lamotrigine; oral
2.9
19.6
95
339
PA2BG
NOMESCO Finland
MRI examination of vessels in the head with high intensity magnet
17.8
19.5
30
17
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
1.5
19.3
805
5909
R26.8
ICD-10 Finland
Other and unspecified abnormalities of gait and mobility
3.0
19.0
85
290
SPAT1301
SPAT
No procedures
1.5
19.0
909
6850
X59
ICD-10 Finland
Exposure to unspecified factor
1.6
18.9
487
3210
C08CA05
ATC
nifedipine; systemic
2.0
18.9
223
1172
P29
ICPC
Psychological sympt/compl other
2.3
18.9
143
633
I67.6
ICD-10 Finland
Nonpyogenic thrombosis of intracranial venous system
+∞
18.8
18
*
N05CF01
ATC
zopiclone; oral
1.4
18.7
987
7570
N28
ICPC
Limited function/disability (N)
3.4
18.7
66
195
G40.12
ICD-10 Finland
Simple partial seizures with secondary generalization
7.0
18.6
28
40
N05AX08
ATC
risperidone; systemic
1.8
18.6
305
1783
PAN14
NOMESCO Finland
Plastic repair of arteries internal carotid artery
100.5
18.6
20
*
PA2AC
NOMESCO Finland
Cerebral angiography with X-ray
100.5
18.6
20
*
PA2VT
NOMESCO Finland
Intravascular evacuation of brain artery embolus
190.7
18.5
19
*
OAB41
NOMESCO Finland
Guidance and counselling related to ageing
5.7
18.5
34
60
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.4
18.4
1134
8940
PA6CG
NOMESCO Finland
Extensive MRI examination of neck vasculature with high intensity magnet
16.2
18.3
29
18
M03BX01
ATC
baclofen; systemic
3.6
18.2
59
165
SPAT1254
SPAT
Administration of medicine
1.6
18.1
474
3136
WYA30
NOMESCO Finland
Treatment of a patient needing special arrangements
2.0
18.0
211
1107
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.5
18.0
829
6191
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
1.4
17.8
925
7059
C10AA07
ATC
rosuvastatin; oral
1.5
17.8
872
6584
2161
FHL
Neck ligation, big brain
+∞
17.7
17
*
PA2YT
NOMESCO Finland
Cerebral artery PTA with stent
+∞
17.7
17
*
N06AX21
ATC
duloxetine; oral
1.8
17.7
289
1686
J69.0
ICD-10 Finland
Pneumonitis due to food and vomit
2.9
17.7
83
291
E11.5
ICD-10 Finland
Type 2 diabetes mellitus, with peripheral circulatory complications
2.8
17.7
87
313
SPAT1053
SPAT
Memory test
1.6
17.6
545
3744
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
2.3
17.5
136
609
TPH07
NOMESCO Finland
Cathetrisation of artery
1.7
17.5
343
2108
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.8
17.2
292
1722
280
Kela drug reimbursment
Clopidogrel
3.2
17.2
67
211
R11
ICD-10 Finland
Nausea and vomiting
1.8
17.1
258
1469
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.6
17.1
509
3467
C01DA02
ATC
glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal
1.4
17.0
816
6127
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.4
16.9
917
7039
J01DB01
ATC
cefalexin; oral
1.4
16.8
2214
19742
AXX01
NOMESCO Finland
Memory assessment
4.6
16.7
39
85
R47.8
ICD-10 Finland
Other and unspecified speech disturbances
4.6
16.7
39
85
G46.7
ICD-10 Finland
Other lacunar syndromes
63.5
16.7
19
*
I62.0
ICD-10 Finland
Nontraumatic subdural haemorrhage
63.5
16.7
19
*
43800
ICD-8 Finland
Other and ill-defined cerebrovascular disease, With hypertension (benign)
+∞
16.7
16
*
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.7
16.7
335
2071
C07AB02
ATC
metoprolol; systemic
1.5
16.6
707
5184
J01DA01
ATC
[U] cefalexin
1.4
16.6
1685
14364
B01AB05
ATC
enoxaparin; parenteral
1.4
16.6
879
6718
N03AX18
ATC
lacosamide; systemic
6.7
16.5
26
39
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
2.2
16.5
148
704
R1250
NOMESCO Finland
Evaluation of functional capability
2.8
16.4
84
309
N06AA09
ATC
amitriptyline; systemic
1.8
16.4
281
1663
I70.9
ICD-10 Finland
Generalized and unspecified atherosclerosis
2.8
16.3
83
304
Z3231
NOMESCO Finland
Registered nurse
1.5
16.3
737
5465
R51
ICD-10 Finland
Headache
2.3
16.2
122
539
ZXE15
NOMESCO Finland
Procedure duration 120 to 149 minutes
4.2
16.2
42
100
2500A
ICD-9 Finland
Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE,TYYPPI II]
2.3
15.9
126
570
F06.7
ICD-10 Finland
Mild cognitive disorder
2.2
15.6
126
574
TPX22
NOMESCO Finland
Intravenous arterial thrombolysis
13.8
15.5
26
19
206
Kela drug reimbursment
Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease
1.4
15.5
714
5309
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
1.4
15.4
734
5487
J01CA08
ATC
pivmecillinam; oral
1.4
15.4
996
7857
N03AF01
ATC
carbamazepine; oral, rectal
2.1
15.4
152
750
H81.4
ICD-10 Finland
Vertigo of central origin
4.4
15.4
38
87
G45.8
ICD-10 Finland
Other transient cerebral ischaemic attacks and related syndromes
5.4
15.4
30
56
J01FF01
ATC
clindamycin; systemic
1.4
15.3
697
5165
N01
ICPC
Headache
1.8
15.3
219
1227
N17
ICPC
Vertigo/dizziness
1.6
15.3
387
2535
J01EA01
ATC
trimethoprim; systemic
1.4
15.2
747
5614
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.4
15.2
775
5864
A06AD11
ATC
lactulose; oral
1.5
15.2
551
3908
N05BA04
ATC
oxazepam; oral
1.4
15.1
722
5397
Z02.7
ICD-10 Finland
Issue of medical certificate
1.9
15.1
211
1173
A10AA02, ,
ATC
2.3
15.0
114
507
Z2446
NOMESCO Finland
Social worker
2.0
14.8
163
837
E10.7
ICD-10 Finland
Type 1 diabetes mellitus, With multiple complications
3.1
14.7
61
200
I65.0
ICD-10 Finland
Occlusion and stenosis of vertebral artery
+∞
14.6
14
*
4300A
ICD-9 Finland
Subarachnoid haemorrhage[HAEMORRHAGIA SUBARACHNOID. POST ANEURYSMA SACCULARE]
+∞
14.6
14
*
I60.8
ICD-10 Finland
Other subarachnoid haemorrhage
150.4
14.5
15
*
PA6AG
NOMESCO Finland
Limited MRI examination of neck vasculature with high intensity magnet
12.6
14.3
25
20
A04
ICPC
Weakness/tiredness general
1.5
14.3
459
3167
A10BA02
ATC
metformin; oral
1.4
14.3
856
6648
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
2.1
14.3
134
648
L28
ICPC
Limited function/disability (L)
1.5
14.2
618
4536
SPAT1224
SPAT
Implementation of speech therapy rehabilitation plan
3.7
14.0
43
116
F31.4
ICD-10 Finland
Bipolar affective disorder, current episode severe depression without psychotic symptoms
4.9
14.0
30
61
ZXD05
NOMESCO Finland
Urgent procedure
1.4
13.7
785
6043
A49.9
ICD-10 Finland
Bacterial infection, unspecified
1.6
13.7
371
2464
F01.2
ICD-10 Finland
Subcortical vascular dementia
4.7
13.7
31
66
4359X
ICD-9 Finland
Transient cerebral ischaemia, Unspecified transient cerebral ischaemia
6.2
13.7
23
37
M48.0
ICD-10 Finland
Spinal stenosis
1.6
13.7
393
2646
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
2.2
13.7
112
514
R13
ICD-10 Finland
Dysphagia
1.8
13.6
205
1166
N39.4
ICD-10 Finland
Other specified urinary incontinence
1.7
13.6
272
1678
4371A
ICD-9 Finland
Other and ill-defined cerebrovascular disease, Other generalised ischaemic cerebrovascular disease
+∞
13.5
13
*
I65.3
ICD-10 Finland
Occlusion and stenosis of multiple and bilateral precerebral arteries
+∞
13.5
13
*
I60.7
ICD-10 Finland
Subarachnoid haemorrhage from intracranial artery, unspecified
+∞
13.5
13
*
PA7CC
NOMESCO Finland
Very extensive angiography of arteries of neck and brain
34.1
13.5
17
5
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.4
13.5
894
7051
P03
ICPC
Feeling depressed
1.9
13.4
166
887
N06AX16
ATC
venlafaxine; oral
1.7
13.4
281
1754
XF404
NOMESCO Finland
Ambulatory ECG
1.7
13.4
257
1567
ZXD35
NOMESCO Finland
Usual procedure
2.4
13.4
93
398
F01.10
ICD-10 Finland
Multi-infarct dementia without additional symptoms
18.3
13.3
20
11
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
2.1
13.3
131
646
G41.9
ICD-10 Finland
Status epilepticus, unspecified
6.3
13.2
22
35
Z50.5
ICD-10 Finland
Speech therapy
4.1
13.2
36
89
Q28.3
ICD-10 Finland
Other malformations of cerebral vessels
13.8
13.2
22
16
C10AA04
ATC
fluvastatin; oral
1.6
13.2
296
1881
M79.6
ICD-10 Finland
Pain in limb
1.3
13.2
1086
8854
F05.9
ICD-10 Finland
Delirium, unspecified
2.5
13.1
83
340
C09CA01
ATC
losartan; oral
1.4
13.1
749
5760
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
1.7
13.1
277
1734
A10AB01
ATC
insulin (human); parenteral
2.4
13.1
92
396
F80.1
ICD-10 Finland
Expressive language disorder
5.5
13.0
25
46
XCK10
NOMESCO Finland
Photography of fundus of eye
1.6
12.9
280
1763
SPAT1231
SPAT
Assessment of adjustments needed in living environment
2.7
12.9
70
266
G51.0
ICD-10 Finland
Bell palsy
2.6
12.9
76
301
H53.9
ICD-10 Finland
Visual disturbance, unspecified
2.3
12.9
95
417
N06CA01
ATC
amitriptyline and psycholeptics; systemic
1.7
12.9
263
1630
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
1.6
12.9
360
2409
H36.03
ICD-10 Finland
Proliferative diabetic retinopathy
5.0
12.8
27
54
N02BF01
ATC
gabapentin; oral
1.7
12.8
260
1611
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
2.1
12.7
119
577
SPAT1222
SPAT
Counselling/guidance promoting independent living
1.5
12.6
478
3407
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
1.6
12.6
279
1766
Z2221
NOMESCO Finland
Medical doctor
1.4
12.5
672
5106
I60.0
ICD-10 Finland
Subarachnoid haemorrhage from carotid siphon and bifurcation
+∞
12.5
12
*
AAL00
NOMESCO Finland
Endovascular occlusion of intracranial aneurysm
+∞
12.5
12
*
I61.3
ICD-10 Finland
Intracerebral haemorrhage in brain stem
+∞
12.5
12
*
4349A
ICD-9 Finland
Occlusion of cerebral arteries, Cerebral artery occlusion, unspecified[OCCL/STENOS ARTER.CEREBRALES NUD CUM INFARCTU CEREB]
+∞
12.5
12
*
AAF05
NOMESCO Finland
Ventriculoperitoneal shunt
3.5
12.5
42
121
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
1.7
12.4
228
1373
PA6BG
NOMESCO Finland
MRI examination of neck vasculature with high intensity magnet
10.0
12.4
24
24
I69.2
ICD-10 Finland
Sequelae of other nontraumatic intracranial haemorrhage
130.3
12.4
13
*
AN1
HP
Coronary angiography
1.5
12.4
374
2543
OAB76
NOMESCO Finland
General guidance on nutrition and food
5.6
12.4
23
41
E78.00
ICD-10 Finland
Familial hypercholesterolaemia
2.1
12.4
124
616
Z3229
NOMESCO Finland
Other healthcare associate professional
1.7
12.2
250
1552
C08CA02
ATC
felodipine; oral
1.6
12.1
316
2081
A10BB12
ATC
glimepiride; oral
1.7
12.1
252
1571
XCW99
NOMESCO Finland
Other investigative procedure of eye
1.6
12.0
319
2107
I50.0
ICD-10 Finland
Congestive heart failure
1.6
11.9
327
2178
C02AC05
ATC
moxonidine; oral
1.9
11.9
140
737
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.7
11.8
201
1185
RS222, ,
NOMESCO Finland
3.6
11.8
38
106
R26.2
ICD-10 Finland
Difficulty in walking, not elsewhere classified
3.0
11.8
50
166
N29
ICPC
Neurological sympt/complt other
2.7
11.8
62
232
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
2.2
11.8
103
486
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
2.3
11.8
90
402
Q28.2
ICD-10 Finland
Arteriovenous malformation of cerebral vessels
14.7
11.8
19
13
G44.1
ICD-10 Finland
Vascular headache, not elsewhere classified
5.9
11.8
21
36
N06AB03
ATC
fluoxetine; oral
1.6
11.7
280
1805
W19
ICD-10 Finland
Unspecified fall
1.6
11.7
277
1783
PF1AT
NOMESCO Finland
Intravascular dilatation of arteries of knee, lower leg and ankle (PTA)
3.4
11.6
40
117
H3603, E103,
ICD-10 Finland
5.5
11.6
22
40
I20.81
ICD-10 Finland
Other angina pectoris stenosed coronary artery
1.6
11.6
281
1818
NA7CG
NOMESCO Finland
Spine and spinal cord extensive MRI examination with high intensity magnet
3.6
11.6
37
103
A10AD05
ATC
insulin aspart; parenteral
2.4
11.5
74
306
N03AE01
ATC
clonazepam; systemic
1.9
11.5
146
788
I67.5
ICD-10 Finland
Moyamoya disease
+∞
11.5
11
*
PA2LT
NOMESCO Finland
Endovascular closure of extensive brain aneurysm
+∞
11.5
11
*
NHQ40
NOMESCO Finland
Amputation of toe
2.7
11.4
62
236
PA2CG
NOMESCO Finland
Extensive MRI examination of vessels in the head with high intensity magnet
13.6
11.4
19
14
I61.8
ICD-10 Finland
Other intracerebral haemorrhage
120.2
11.4
12
*
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.4
11.4
774
6098
SPAT1263
SPAT
Sampling
1.3
11.4
1069
8832
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
2.6
11.4
64
248
UJF32
NOMESCO Finland
Coloscopy
1.4
11.4
736
5755
81
HP
Angiography of the heart and coronary arteries
1.7
11.3
233
1447
25000
ICD-8 Finland
Diabetes mellitus, Sine complicatione
2.3
11.3
88
396
4351A
ICD-9 Finland
Transient cerebral ischaemia, Vertebral artery syndrome
11.8
11.3
20
17
I50.9
ICD-10 Finland
Heart failure, unspecified
1.4
11.3
597
4517
A01
ICPC
Pain general/multiple sites
1.6
11.2
276
1791
A10AE05
ATC
insulin detemir; parenteral
1.9
11.2
145
787
G91.1
ICD-10 Finland
Obstructive hydrocephalus
8.9
11.2
23
26
ZXA05
NOMESCO Finland
Left side
1.4
11.2
697
5414
RS221, ,
NOMESCO Finland
3.5
11.2
38
110
JDB10
NOMESCO Finland
Percutaneous gastrostomy
3.3
11.2
42
130
ZXA00
NOMESCO Finland
Right side
1.4
11.1
739
5799
40199
ICD-8 Finland
Essential benign hypertension
2.3
11.1
84
374
I25.0
ICD-10 Finland
Atherosclerotic cardiovascular disease, so described
1.7
11.1
222
1370
N02AJ06
ATC
codeine and paracetamol; systemic
1.3
11.0
996
8178
215
Kela drug reimbursment
Diabetes, non-insulin-treated
1.4
11.0
651
5017
A10BB01
ATC
glibenclamide; oral
1.8
11.0
181
1059
213
Kela drug reimbursment
Fat metabolism disorder associated with chronic coronary artery disease
1.6
10.9
274
1786
I25.2
ICD-10 Finland
Old myocardial infarction
1.6
10.9
256
1642
I68.0*E85.9
ICD-10 Finland
Cerebral amyloid angiopathy
43.4
10.9
13
*
A02BC03
ATC
lansoprazole; oral
1.3
10.9
792
6299
R52.9
ICD-10 Finland
Pain, unspecified
1.6
10.9
253
1620
C08CA13
ATC
lercanidipine; oral
1.5
10.8
428
3074
M01AE03
ATC
ketoprofen; systemic, rectal
1.3
10.8
1010
8328
H02AB06
ATC
prednisolone; systemic
1.3
10.8
1291
11002
F01.20
ICD-10 Finland
Subcortical vascular dementia without additional symptoms
3.3
10.8
39
118
F31.9
ICD-10 Finland
Bipolar affective disorder, unspecified
2.9
10.8
49
170
79199
ICD-8 Finland
Headache
2.9
10.7
50
176
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
1.6
10.7
253
1627
S22.3
ICD-10 Finland
Fracture of rib
1.7
10.7
209
1281
C03AA03
ATC
hydrochlorothiazide; oral
1.6
10.7
285
1886
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.3
10.6
814
6521
H3603, E113,
ICD-10 Finland
3.5
10.5
35
100
F33.11
ICD-10 Finland
Recurrent depression, moderate episode of somatic syndrome
2.9
10.5
47
162
I61.4
ICD-10 Finland
Intracerebral haemorrhage in cerebellum
+∞
10.4
10
*
I65.1
ICD-10 Finland
Occlusion and stenosis of basilar artery
+∞
10.4
10
*
I67.7
ICD-10 Finland
Cerebral arteritis, not elsewhere classified
+∞
10.4
10
*
PA2KT
NOMESCO Finland
Endovascular closure of brain aneurysm
+∞
10.4
10
*
43300
ICD-8 Finland
Cerebral thrombosis, Wtih hypertension (benign)
+∞
10.4
10
*
SPAT1240
SPAT
Therapeutic discussion
1.7
10.4
181
1075
Z71.8
ICD-10 Finland
Other specified counselling
1.3
10.3
759
6040
SPAT1360
SPAT
Extensive global examination
1.7
10.3
193
1171
C02DE04, ,
ATC
2.0
10.3
112
575
SPAT1081
SPAT
Cardiorespiratory global assessment
1.7
10.2
170
997
I20.01
ICD-10 Finland
Unstable angina
2.0
10.2
107
542
C09CA06
ATC
candesartan; oral
1.4
10.1
597
4589
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
1.7
10.1
167
977
R90.8
ICD-10 Finland
Other abnormal findings on diagnostic imaging of central nervous system
3.7
10.1
31
84
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.3
10.1
1182
10020
M79.0
ICD-10 Finland
Rheumatism, unspecified
2.2
10.0
79
358
XXA00
NOMESCO Finland
Clinical examination requiring general anaesthesia
8.4
10.0
21
25
AAD10
NOMESCO Finland
Evacuation of chronic subdural haematoma
3.1
10.0
41
134
NA1AD
NOMESCO Finland
Cervical spine CT examination
1.9
9.9
127
688
G43.0
ICD-10 Finland
Migraine without aura [common migraine]
2.2
9.9
82
379
A12BA01
ATC
potassium chloride; oral
1.7
9.9
180
1083
F01.3
ICD-10 Finland
Mixed cortical and subcortical vascular dementia
7.6
9.9
22
29
F03
ICD-10 Finland
Unspecified dementia
1.7
9.9
192
1176
V700A
ICD-9 Finland
General medical examination, Routine general medical examination at a health care facility
2.3
9.8
70
304
H81.2
ICD-10 Finland
Vestibular neuronitis
2.5
9.8
60
243
H49.0
ICD-10 Finland
Third [oculomotor] nerve palsy
5.1
9.8
20
39
M53.1
ICD-10 Finland
Cervicobrachial syndrome
1.6
9.8
231
1485
R06.0
ICD-10 Finland
Dyspnoea
1.3
9.8
784
6310
E78.9
ICD-10 Finland
Disorder of lipoprotein metabolism, unspecified
2.0
9.7
105
537
ZXE17
NOMESCO Finland
Procedure duration 150 to 179 minutes
4.5
9.7
23
51
N05CD07
ATC
temazepam; oral
1.4
9.7
397
2864
G45.3
ICD-10 Finland
Amaurosis fugax
2.6
9.7
53
203
PEF23
NOMESCO Finland
Thrombendarterectomy of femoral artery
2.6
9.7
54
209
H81.1
ICD-10 Finland
Benign paroxysmal vertigo
1.5
9.7
272
1821
K99
ICPC
Cardiovascular disease other
2.1
9.6
94
464
IBA04
NOMESCO Finland
Extensive initial psychiatric evaluation
3.6
9.6
31
87
CKC12
NOMESCO Finland
Photocoagulation of retina
2.0
9.6
102
520
C09DA01
ATC
losartan and diuretics; oral
1.5
9.5
300
2056
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
2.0
9.5
99
500
E11.3
ICD-10 Finland
Type 2 diabetes mellitus, with ophthalmic complications
2.1
9.5
91
446
P99
ICPC
Psychological disorders other
2.5
9.5
56
223
A10BH01
ATC
sitagliptin; oral
1.5
9.5
271
1821
4373A
ICD-9 Finland
Other and ill-defined cerebrovascular disease, Cerebral aneurysm, nonruptured
+∞
9.4
9
*
I69.4
ICD-10 Finland
Sequelae of stroke, not specified as haemorrhage or infarction
+∞
9.4
9
*
N30
ICD-10 Finland
Cystitis
1.7
9.4
185
1138
NE1AA
NOMESCO Finland
Pelvis X-ray examination
1.6
9.4
234
1525
7890A
ICD-9 Finland
Other symptoms involving abdomen and pelvis, Abdominal pain
1.9
9.4
124
680
C09AA02
ATC
enalapril; systemic
1.4
9.3
605
4714
I20.09
ICD-10 Finland
Unstable angina
1.6
9.3
195
1217
A46
ICD-10 Finland
Erysipelas
1.4
9.3
431
3180
F31.30
ICD-10 Finland
Bipolar disorder Depressive episode without somatic syndrome
3.5
9.3
31
89
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.5
9.3
308
2134
UKC02
NOMESCO Finland
Cystoscopy
1.4
9.3
515
3917
G50.1
ICD-10 Finland
Atypical facial pain
2.8
9.2
46
168
WX704
NOMESCO Finland
Intubation
1.6
9.2
192
1197
F32.11
ICD-10 Finland
Moderate depressive episode with somatic syndrome
2.6
9.2
53
209
SPAT1101
SPAT
Orthostatic test
1.7
9.2
155
914
4350A
ICD-9 Finland
Transient cerebral ischaemia, Basilar artery syndrome
7.7
9.1
20
26
N06AB06
ATC
sertraline; oral
1.6
9.1
223
1447
C03EA01
ATC
hydrochlorothiazide and potassium-sparing agents; oral
1.4
9.1
503
3824
S00.0
ICD-10 Finland
Superficial injury of scalp
2.2
9.1
76
354
H25.1
ICD-10 Finland
Senile nuclear cataract
1.3
9.1
1008
8458
M54.4
ICD-10 Finland
Lumbago with sciatica
1.4
9.0
392
2859
NF1AE
NOMESCO Finland
Hip joint ultrasound examination
2.4
9.0
59
247
G43.3
ICD-10 Finland
Complicated migraine
3.4
9.0
31
91
5541
FHL
Subclavia and / or carotid endarterectomy, reconstruction or bypass surgery
36.7
9.0
11
*
S97
ICPC
Chronic ulcer skin
1.6
8.8
199
1265
K59.1
ICD-10 Finland
Functional diarrhoea
1.7
8.8
150
886
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
1.8
8.8
139
804
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
1.6
8.8
205
1314
I21.49
ICD-10 Finland
Acute subendocardial infarction unspecified coronary artery status
1.6
8.8
207
1331
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.4
8.8
394
2891
G90.2
ICD-10 Finland
Horner syndrome
9.5
8.7
17
18
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.3
8.7
683
5465
SPAT1295
SPAT
Other function in accordance with physical therapy nomenclature
1.8
8.7
125
703
P76
ICPC
Depressive disorder
1.9
8.7
107
573
IBA01
NOMESCO Finland
Diagnostic and symptom-mapping evaluation
3.7
8.7
27
74
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.3
8.7
979
8218
N06DA04
ATC
galantamine; oral
2.0
8.6
97
504
I20.99
ICD-10 Finland
Angina pectoris, unspecified
1.6
8.6
229
1513
Q21.11
ICD-10 Finland
Paten or persistent foramen ovale
11.6
8.5
15
13
F01
ICD-10 Finland
Vascular dementia
6.4
8.5
21
33
IGY02
NOMESCO Finland
Psychiatric monitoring contact
2.4
8.5
56
236
L98.4
ICD-10 Finland
Chronic ulcer of skin, not elsewhere classified
2.1
8.4
74
351
C08CA10
ATC
nilvadipine; oral
2.3
8.4
62
274
AAK80
NOMESCO Finland
Partial excision of skull cap
90.1
8.4
9
*
T36
ICD-10 Finland
Poisoning by systemic antibiotics
2.1
8.4
76
365
SPAT1260
SPAT
Consultation of another employee
1.4
8.4
434
3261
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
1.7
8.4
143
847
E0000UV, ,
ATC
1.3
8.4
1015
8589
E10.6
ICD-10 Finland
Type 1 diabetes mellitus, With other specified complications
4.9
8.3
18
37
43099
ICD-8 Finland
Subarachnoid haemorrhage, Without mention of hypertension
+∞
8.3
8
*
I67.4
ICD-10 Finland
Hypertensive encephalopathy
+∞
8.3
8
*
R48.2
ICD-10 Finland
Apraxia
+∞
8.3
8
*
I61.6
ICD-10 Finland
Intracerebral haemorrhage, multiple localized
+∞
8.3
8
*
N88
ICPC
Epilepsy
4.6
8.3
19
41
XFP96
NOMESCO Finland
Other intraoperative electrophysiological investigation in arhythmia or disturbance of impulse propagation
2.3
8.2
61
270
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
1.5
8.2
267
1841
N30.9
ICD-10 Finland
Cystitis, unspecified
1.6
8.2
180
1138
183
Kela drug reimbursment
Lamotrigin and topiramate
4.2
8.2
21
50
L30.9
ICD-10 Finland
Dermatitis, unspecified
1.4
8.2
472
3609
ZXY02
NOMESCO Finland
Neuropsychologist
7.5
8.1
18
24
M54.8
ICD-10 Finland
Other dorsalgia
1.8
8.1
107
587
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
2.1
8.1
73
351
F01.19
ICD-10 Finland
Multi-infarct dementia without information on additional symptoms
8.1
8.1
17
21
PA4AC
NOMESCO Finland
Vertebralis angiography with X-ray
17.2
8.1
12
7
Z43.5
ICD-10 Finland
Attention to cystostomy
3.3
8.0
29
88
FFC22
NOMESCO Finland
Percutaneous transluminal closure of ostium secundum type ASD
22.0
8.0
11
5
Z00.0
ICD-10 Finland
General medical examination
1.4
8.0
474
3638
A02BA02
ATC
ranitidine; systemic
1.3
8.0
559
4398
Z04.9
ICD-10 Finland
Examination and observation for unspecified reason
1.9
8.0
102
554
PD4CC
NOMESCO Finland
Very extensive arterigography of lower extremity with X-ray
3.6
8.0
25
69
FPK00
NOMESCO Finland
Implantation of electrocardiograph with loop recorder
4.1
8.0
21
51
L89
ICD-10 Finland
Decubitus ulcer and pressure area
2.1
8.0
70
333
SPAT1251
SPAT
Organisation of medication
1.8
7.9
108
598
ZXD10
NOMESCO Finland
Scheduled procedure
1.3
7.9
960
8109
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
1.6
7.9
197
1283
K59.0
ICD-10 Finland
Constipation
1.6
7.9
171
1078
H04.10
ICD-10 Finland
Dry eye syndrome
1.5
7.9
262
1816
M03BC01
ATC
orphenadrine (citrate); systemic
1.4
7.9
432
3276
J09
ICD-10 Finland
Influenza due to identified zoonotic or pandemic influenza virus
2.0
7.9
81
409
G04CA02
ATC
tamsulosin; oral
1.3
7.8
797
6589
G47.3
ICD-10 Finland
Sleep apnoea
1.3
7.8
492
3809
7231A
ICD-9 Finland
Other disorders of cervical region, Cervicalgia
2.8
7.8
37
132
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
1.5
7.8
238
1621
M54.5
ICD-10 Finland
Low back pain
1.3
7.8
830
6901
SPAT1292
SPAT
Other function in accordance with SHToL (Finnish classification of nursing interventions)
1.5
7.8
259
1796
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
1.6
7.8
181
1161
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
2.1
7.8
68
323
D11
ICPC
Diarrhoea
1.5
7.8
242
1656
XF600
NOMESCO Finland
Bloodpressure measurement
1.6
7.7
164
1028
J01DA09
ATC
[U] cefadroxil
1.3
7.7
622
4989
IER02
NOMESCO Finland
Dedicated profession-specific psychiatric intervention, group
4.2
7.7
20
48
C08CA06
ATC
nimodipine; systemic
45.0
7.7
9
*
C10AA02
ATC
lovastatin; oral
1.7
7.7
137
821
C09AA04
ATC
perindopril; oral
1.7
7.7
140
844
R33
ICD-10 Finland
Retention of urine
1.5
7.6
274
1929
AA1DM
NOMESCO Finland
Very extensive MRI examination of brain with 3 Tesla magnet
4.5
7.6
18
40
FM1CD
NOMESCO Finland
Very extensive CT of heart
8.0
7.6
16
20
N02AA05
ATC
oxycodone; systemic
1.3
7.6
571
4537
SPAT1050
SPAT
Extensive neurological examination
2.2
7.6
60
274
N05BA01
ATC
diazepam; systemic, rectal
1.4
7.6
325
2365
NA1CG
NOMESCO Finland
Cervical spine extensive MRI examination with high intensity magnet
2.6
7.6
43
169
B01AE07
ATC
dabigatran etexilate; oral
1.8
7.6
111
630
J01AA02
ATC
doxycycline; systemic
1.3
7.5
2091
19318
A10AB04
ATC
insulin lispro; parenteral
2.1
7.5
65
307
M47.80
ICD-10 Finland
Other spondylosis, multiple sites in spine
2.0
7.5
78
395
XF620
NOMESCO Finland
Examination of circulation with color method
6.1
7.5
19
31
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
1.7
7.5
133
796
N02CC01
ATC
sumatriptan; nasal, systemic, rectal
1.6
7.5
183
1187
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.4
7.5
443
3397
U07.1
ICD-10 Finland
Emergency use of U07.1 | COVID-19, virus identified
1.4
7.5
350
2585
4029A
ICD-9 Finland
Hypertensive heart disease, Unspecified[DECOMPENSATIO CORDIS NON INDICATA (WHO II)]
3.0
7.5
32
108
F60.9
ICD-10 Finland
Personality disorder, unspecified
3.7
7.4
23
63
G46.5
ICD-10 Finland
Pure motor lacunar syndrome
80.1
7.4
8
*
H36.00
ICD-10 Finland
Diabetic background retinopathy
2.7
7.4
37
136
H36.09*E10.3
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic retinopathy
4.4
7.4
18
41
S80.0
ICD-10 Finland
Contusion of knee
1.6
7.4
155
970
R60.0
ICD-10 Finland
Localized oedema
1.4
7.3
356
2644
NHQ30
NOMESCO Finland
Amputation of foot, transmetatarsal
3.7
7.3
22
59
SPAT1215
SPAT
Assessment of need for medical rehabilitation
1.9
7.3
94
512
C08DB01
ATC
diltiazem; oral
1.5
7.3
191
1259
G93.4
ICD-10 Finland
Encephalopathy, unspecified
8.4
7.3
15
18
S01.3
ICD-10 Finland
Open wound of ear
2.8
7.3
35
126
4341A
ICD-9 Finland
Occlusion of cerebral arteries, Cerebral embolism
+∞
7.3
7
*
I68.8
ICD-10 Finland
Other cerebrovascular disorders in diseases classified elsewhere
+∞
7.3
7
*
AAB30
NOMESCO Finland
Evacuation of spontaneous intracranial haematoma
+∞
7.3
7
*
I61.5
ICD-10 Finland
Intracerebral haemorrhage, intraventricular
+∞
7.3
7
*
4331X
ICD-9 Finland
Occlusion and stenosis of precerebral arteries, Carotid artery[OCCL/STENOSIS ARTERIAE CAROTIS SINE INFARCTU CEREBR]
+∞
7.3
7
*
I60.1
ICD-10 Finland
Subarachnoid haemorrhage from middle cerebral artery
+∞
7.3
7
*
I63.6
ICD-10 Finland
Cerebral infarction due to cerebral venous thrombosis, nonpyogenic
+∞
7.3
7
*
4331A
ICD-9 Finland
Occlusion and stenosis of precerebral arteries, Carotid artery[OCCL/STENOSIS ARTERIAE CAROTIS CUM INFARCTU CEREBRI]
+∞
7.3
7
*
SPAT1284
SPAT
Extensive health certificate
2.2
7.3
57
259
GD1AD
NOMESCO Finland
Thorax CT examination
1.6
7.3
167
1068
SPAT1234
SPAT
Support of social functional capacity
1.6
7.3
162
1029
SPAT1245
SPAT
Provision of support and information to patient’s family members
1.6
7.3
151
943
U02
ICPC
Urinary frequency/urgency
1.4
7.2
359
2676
R3110
NOMESCO Finland
Psychosocial training
4.1
7.2
19
46
S82.6
ICD-10 Finland
Fracture of lateral malleolus
1.6
7.2
143
882
R06AE07
ATC
cetirizine; oral
1.2
7.2
959
8170
AA1AM
NOMESCO Finland
Short MRI examination of brain with 3 Tesla magnet
15.7
7.2
11
7
OAB48
NOMESCO Finland
Lifestyle advice and guidance
4.3
7.2
18
42
ZXE10
NOMESCO Finland
More than one and less than three hours
1.3
7.2
887
7493
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
1.5
7.2
221
1510
C03DA01
ATC
spironolactone; oral
1.4
7.1
385
2911
G04BD07
ATC
tolterodine; oral
1.6
7.1
151
948
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.3
7.1
629
5102
N06AX22
ATC
agomelatine; oral
2.6
7.1
38
145
D07AA02
ATC
hydrocortisone; topical
1.4
7.1
303
2203
N06AX12
ATC
bupropion; oral
1.8
7.1
95
525
J01MA06
ATC
norfloxacin; oral
1.4
7.1
337
2496
PA3AC
NOMESCO Finland
Carotis angiography with X-ray
12.0
7.1
12
10
NA7BG
NOMESCO Finland
Spine and spinal cord MRI examination with high intensity magnet
6.0
7.1
18
30
N18.8
ICD-10 Finland
Other chronic renal failure
1.9
7.0
79
412
E11.6
ICD-10 Finland
Type 2 diabetes mellitus, with other specified complications
2.1
7.0
62
296
SPAT1252
SPAT
Overall medication plan or its review
1.5
7.0
194
1295
X58
ICD-10 Finland
Exposure to other specified factors
1.4
7.0
302
2199
K08.3
ICD-10 Finland
Retained dental root
1.5
7.0
191
1273
R51.81
ICD-10 Finland
Facial pain NOS
2.3
7.0
52
232
T90.5
ICD-10 Finland
Sequelae of intracranial injury
3.2
7.0
27
86
XX3XW, ,
NOMESCO Finland
3.9
7.0
20
52
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
1.7
6.9
123
737
FN1AT
NOMESCO Finland
Endovascular dilatation of coronary arteries (PTCA)
1.6
6.9
148
931
J01FA06
ATC
roxithromycin; oral
1.2
6.9
977
8373
R07.3
ICD-10 Finland
Other chest pain
1.4
6.9
257
1822
G40
ICD-10 Finland
Epilepsy
3.7
6.9
21
57
7804A
ICD-9 Finland
General symptoms, Dizziness and giddiness
2.3
6.9
51
227
W10
ICD-10 Finland
Fall on and from stairs and steps
1.7
6.9
130
793
Z95.1
ICD-10 Finland
Presence of aortocoronary bypass graft
1.6
6.8
140
871
H81.3
ICD-10 Finland
Other peripheral vertigo
2.0
6.8
73
374
J45.0
ICD-10 Finland
Predominantly allergic asthma
1.6
6.8
175
1149
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.3
6.8
475
3729
WX872
NOMESCO Finland
Intensive care
1.7
6.8
123
741
SPAT1221
SPAT
Guidance concerning rehabilitation services and livelihood
2.4
6.8
43
178
SPAT1296
SPAT
Other function in accordance with occupational therapy nomenclature
2.8
6.8
32
114
NFQ20
NOMESCO Finland
Amputation of femur
2.8
6.8
32
114
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
1.8
6.8
101
576
FN1BC
NOMESCO Finland
Extensive angiography of hear and/or coronary arteries
1.6
6.8
147
928
H3601, E113,
ICD-10 Finland
2.4
6.8
46
197
P01
ICPC
Feeling anxious/nervous/tense
1.6
6.7
156
1001
C07AA07
ATC
sotalol; systemic
1.7
6.7
130
799
XX1XW
NOMESCO Finland
Extensive written report from radiologist
2.2
6.7
51
230
M02AA07
ATC
piroxicam; topical
1.2
6.7
971
8341
U04
ICPC
Incontinence urine
1.5
6.7
176
1164
SPAT1243
SPAT
Psychiatric/psychological examination
2.6
6.6
37
145
F34.1
ICD-10 Finland
Dysthymia
2.0
6.6
67
338
ACC59
NOMESCO Finland
Decompression and freeing of adhesions of peripheral nerve: other or unspecified
1.7
6.6
111
657
B99
ICD-10 Finland
Other and unspecified infectious diseases
2.1
6.6
59
284
A06AC51
ATC
ispaghula, combinations; oral
1.7
6.6
114
680
SPAT1262
SPAT
Handing over of treatment supplies
1.3
6.6
452
3542
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
1.5
6.5
208
1431
G63.2*E10.4
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic polyneuropathy
10.0
6.5
12
12
M54.2
ICD-10 Finland
Cervicalgia
1.6
6.5
165
1082
N02BF02
ATC
pregabalin; oral
1.6
6.5
143
907
Z31.5
ICD-10 Finland
Genetic counselling
1.8
6.5
85
467
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.2
6.5
1172
10290
AA1BD
NOMESCO Finland
Extensive CT of head and brain
2.0
6.5
62
306
E10.9
ICD-10 Finland
Type 1 diabetes mellitus, Without complications
1.9
6.5
74
389
QDG20
NOMESCO Finland
Operation for chronic ulcer or fistula of skin of lower limb
2.8
6.4
31
112
PD4BC
NOMESCO Finland
Extensive arterigography of lower extremity with X-ray
2.3
6.4
47
208
I62.9
ICD-10 Finland
Intracranial haemorrhage (nontraumatic), unspecified
69.9
6.4
7
*
F01.29
ICD-10 Finland
Subcortical vascular dementia without information on additional symptoms
3.9
6.4
18
46
SPAT1279
SPAT
Preparation of immediate hospitalisation
2.4
6.4
41
171
H34.1
ICD-10 Finland
Central retinal artery occlusion
3.5
6.4
21
60
E11.1
ICD-10 Finland
Type 2 diabetes mellitus, with ketoacidosis
3.5
6.4
21
60
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
1.4
6.4
288
2113
7819X
ICD-9 Finland
Symptoms involving nervous and musculoskeletal systems, Other symptoms involving nervous and musculoskeletal systems[SYMPTOMATA ALIA SYSTEMATIS NERVORUM ET MUSCULOSCEL]
2.8
6.4
30
107
S06.3
ICD-10 Finland
Focal brain injury
2.7
6.4
33
124
I35.0
ICD-10 Finland
Aortic (valve) stenosis
1.5
6.4
215
1496
J45.1
ICD-10 Finland
Nonallergic asthma
1.5
6.4
171
1135
4130X
ICD-9 Finland
Angina pectoris, Angina decubitus[ANGINA PECTORIS (""""EFFORT ANGINA""""),MÄÄRITTELEMÄT]
1.9
6.4
81
441
F39
ICD-10 Finland
Unspecified mood [affective] disorder
3.0
6.4
27
91
Z73.6
ICD-10 Finland
Limitation of activities due to disability
3.0
6.4
27
91
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.2
6.3
972
8389
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
2.0
6.3
65
330
SPAT1255
SPAT
Intravenous administration of medicine
1.5
6.3
175
1172
PA6CM
NOMESCO Finland
Extensive MRI examination of neck vasculature with 3 Tesla magnet
18.0
6.3
9
5
K22
ICPC
Risk factor cardiovascular disease
1.5
6.3
159
1043
I60.2
ICD-10 Finland
Subarachnoid haemorrhage from anterior communicating artery
+∞
6.2
6
*
PA2MT
NOMESCO Finland
Endovascular closure of very extensive brain aneurysm
+∞
6.2
6
*
I60.3
ICD-10 Finland
Subarachnoid haemorrhage from posterior communicating artery
+∞
6.2
6
*
I60.4
ICD-10 Finland
Subarachnoid haemorrhage from basilar artery
+∞
6.2
6
*
C01AA05
ATC
digoxin; systemic
1.4
6.2
331
2495
S70.0
ICD-10 Finland
Contusion of hip
1.6
6.2
121
744
M03BC51
ATC
orphenadrine, combinations; systemic
1.3
6.2
558
4527
H51.2
ICD-10 Finland
Internuclear ophthalmoplegia
26.7
6.2
8
*
S90.3
ICD-10 Finland
Contusion of other and unspecified parts of foot
2.3
6.2
46
205
C07AB05
ATC
betaxolol; oral
1.9
6.2
77
416
D07AC01
ATC
betamethasone; topical
1.2
6.2
888
7603
NF1BA
NOMESCO Finland
Hip extensive X-ray examination
1.7
6.2
115
699
M03BX02
ATC
tizanidine; oral
1.2
6.2
1342
11981
L04AX01
ATC
azathioprine; systemic
1.8
6.2
82
453
G91.0
ICD-10 Finland
Communicating hydrocephalus
5.0
6.2
18
36
XF602
NOMESCO Finland
Bloodpressure monitoring
2.5
6.2
36
144
N12
ICD-10 Finland
Tubulo-interstitial nephritis, not specified as acute or chronic
2.1
6.1
54
258
JN3AD
NOMESCO Finland
Abdominal CT examination
1.4
6.1
321
2413
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.3
6.1
635
5241
R52.1
ICD-10 Finland
Chronic intractable pain
3.1
6.1
24
77
Z29
ICPC
Social problem NOS
2.2
6.1
50
232
PEN23
NOMESCO Finland
Plastic repair of femoral artery
2.9
6.1
27
93
M96.1
ICD-10 Finland
Postlaminectomy syndrome, not elsewhere classified
3.4
6.1
21
62
S01.0
ICD-10 Finland
Open wound of scalp
1.5
6.1
210
1467
JC2KB
NOMESCO Finland
Functional X-ray examination of swallowing
2.6
6.1
33
127
L02.4
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of limb
1.8
6.1
80
440
D07AB02
ATC
hydrocortisone butyrate; topical
1.3
6.1
699
5839
2500B
ICD-9 Finland
Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]
2.4
6.1
39
163
N05AX12
ATC
aripiprazole; systemic
2.1
6.1
52
246
IBZ01
NOMESCO Finland
Profession-specific psychiatric evaluation
2.7
6.1
31
116
R4160
NOMESCO Finland
Other therapy enhancing rehabilitation
2.3
6.1
42
182
78050
ICD-8 Finland
Certain symptoms referable to nervous system and special senses, Vertigo
2.3
6.0
45
201
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
1.6
6.0
144
931
290
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
1.3
6.0
519
4187
N06AG02
ATC
moclobemide; oral
1.7
6.0
95
552
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
2.9
6.0
27
94
FNA01
NOMESCO Finland
Anastomosis to coronary artery from internal mammary artery, one distal anastamosis
1.6
6.0
145
940
TimeCodeWAS
↥TODO / Current known limitations:
- Only showing the top 500 codes, because showing all (sometimes 20k) makes the page too slow.
- Legend / how to read the glyphs.
- Proper column names.
- Show details (e.g. Fisher or Chi-square test, N cases and N controls) when clicking on a row.
- Explanation on the underlying data / how the TimeCodeWAS is done (e.g. matched cases / controls, eligibility).
- Download CSV not working.
- No filters and sorters.
- Limited amount of endpoints with TimeCodeWAS data.
- Cross-links to Risteys lab test pages for lab test codes.
OMOP Concept
ln(OR) -5y
ln(OR) -1y
ln(OR) -1m
ln(OR) d0
ln(OR) +1m
ln(OR) +1y
ln(OR) +5y
MCC -5y
MCC -1y
MCC -1m
MCC d0
MCC +1m
MCC +1y
MCC +5y
Cerebral infarction due to thrombosis of precerebral arteries
I63.0 (45538393)
I63.0 (45538393)
Cerebral aneurysm, nonruptured
I67.1 (45538401)
I67.1 (45538401)
Other specified cerebrovascular diseases
I67.8 (45543191)
I67.8 (45543191)
Cerebral infarction due to embolism of precerebral arteries
I63.1 (45557550)
I63.1 (45557550)
Cerebral infarction due to thrombosis of cerebral arteries
I63.3 (45562366)
I63.3 (45562366)
Cerebral infarction due to embolism of cerebral arteries
I63.4 (45591475)
I63.4 (45591475)
Cerebral infarction due to unspecified occlusion or stenosis of precerebral arteries
I63.2 (45586592)
I63.2 (45586592)
Cerebral infarction due to unspecified occlusion or stenosis of cerebral arteries
I63.5 (45605808)
I63.5 (45605808)
Other cerebral infarction
I63.8 (45605810)
I63.8 (45605810)
Dissection of cerebral arteries, nonruptured
I67.0 (45605812)
I67.0 (45605812)
Late effects of cerebrovascular disease[SEQUELAE MORBI CEREBROVASCULARIS]
4380A (2000403758)
4380A (2000403758)
Brain stem stroke syndrome (I60-I67+)
G46.3*I67.9 (2000502161)
G46.3*I67.9 (2000502161)
Cerebellar stroke syndrome
G46.4*I67.9 (2000502162)
G46.4*I67.9 (2000502162)
Other lacunar syndromes
G46.7*I67.9 (2000502165)
G46.7*I67.9 (2000502165)
Sequelae of intracerebral haemorrhage
I69.1 (45538404)
I69.1 (45538404)
Cerebellar stroke syndrome
G46.4 (45571809)
G46.4 (45571809)
Nonpyogenic thrombosis of intracranial venous system
I67.6 (45572103)
I67.6 (45572103)
Intracerebral haemorrhage, unspecified
I61.9 (45576882)
I61.9 (45576882)
Brain stem stroke syndrome
G46.3 (45586296)
G46.3 (45586296)
Cerebrovascular disease, unspecified
I67.9 (45586600)
I67.9 (45586600)
Subarachnoid haemorrhage, unspecified
I60.9 (45591472)
I60.9 (45591472)
Intracerebral haemorrhage in hemisphere, subcortical
I61.0 (45605803)
I61.0 (45605803)
Occlusion of cerebral arteries, Cerebral thrombosis
4340A (2000403736)
4340A (2000403736)
Other vascular syndromes of brain in cerebrovascular diseases
G46.8*I67.9 (2000502166)
G46.8*I67.9 (2000502166)
Cerebral very extensive angiography with X-ray
PA2CC (2001300227)
PA2CC (2001300227)
Ligature of intracranial aneurysm
AAC00 (2001300262)
AAC00 (2001300262)
Sequelae of subarachnoid haemorrhage
I69.0 (45543193)
I69.0 (45543193)
Acute but ill-defined cerebrovascular disease[MORBUS CEREBROVASCULARIS ACUTUS NON DEFINITUS]
4360A (2000403745)
4360A (2000403745)
Other and ill-defined cerebrovascular disease, Other[MORBUS CERBROVASCULARIS ALIA DEFINITA]
4378X (2000403755)
4378X (2000403755)
Cerebral extensive angiography with X-ray
PA2BC (2001300225)
PA2BC (2001300225)
SMOKING - SMOKE2: no - SMOKE3: never - SMOKE5: Unspecified
SMOKING-2-3-0 (2002330113)
SMOKING-2-3-0 (2002330113)
Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
22133-3 (3014973)
22133-3 (3014973)
Body height measure
50373000 (4177340)
50373000 (4177340)
Body mass index
60621009 (4245997)
60621009 (4245997)
Progressive vascular leukoencephalopathy
I67.3 (45538402)
I67.3 (45538402)
Obstructive hydrocephalus
G91.1 (45595964)
G91.1 (45595964)
Cerebral infarction, unspecified
I63.9 (45596216)
I63.9 (45596216)
Pure motor lacunar syndrome
G46.5*I67.9 (2000502163)
G46.5*I67.9 (2000502163)
Pure sensory lacunar syndrome
G46.6*I67.9 (2000502164)
G46.6*I67.9 (2000502164)
Extensive MRI examination of brain with 3 Tesla magnet
AA1CM (2001300117)
AA1CM (2001300117)
Very extensive MRI examination of brain with high intensity magnet
AA1DG (2001300120)
AA1DG (2001300120)
CT of cerebral ischaemia
AA5BD (2001300158)
AA5BD (2001300158)
Extensive CT angiography of brain
PA2BD (2001300226)
PA2BD (2001300226)
CT angiography of head and neck vasculature
PA7AD (2001300233)
PA7AD (2001300233)
CT angiography of neck and brain, extensive
PA7CD (2001300238)
PA7CD (2001300238)
Ventriculostomy
AAF00 (2001300294)
AAF00 (2001300294)
Intracranial endovascular thrombolysis
AAL10 (2001300346)
AAL10 (2001300346)
Neuropsychological investigation
XA800 (2001300412)
XA800 (2001300412)
Thrombendarterectomy of internal carotid artery
PAF14 (2001308743)
PAF14 (2001308743)
Neuropsychological rehabilitation
R4150 (2001310239)
R4150 (2001310239)
Psychologist
Z2445 (2001311558)
Z2445 (2001311558)
Clopidogrel
315 (2001600276)
315 (2001600276)
Stroke/cerebrovascular accident
K90 (2002000617)
K90 (2002000617)
SMOKING - SMOKE2: no - SMOKE3: former - SMOKE5: former
SMOKING-2-2-4 (2002330109)
SMOKING-2-2-4 (2002330109)
SMOKING - SMOKE2: no - SMOKE3: former - SMOKE5: Unspecified
SMOKING-2-2-0 (2002330110)
SMOKING-2-2-0 (2002330110)
SMOKING - SMOKE2: no - SMOKE3: never - SMOKE5: never
SMOKING-2-3-5 (2002330114)
SMOKING-2-3-5 (2002330114)
SMOKING - SMOKE2: yes - SMOKE3: current - SMOKE5: Unspecified
SMOKING-1-1-0 (2002330116)
SMOKING-1-1-0 (2002330116)
nimodipine; oral, parenteral
C08CA06 (21601752)
C08CA06 (21601752)
IgG [Mass/volume] in Cerebral spinal fluid
2464-6 (3007368)
2464-6 (3007368)
Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
5013-8 (3008733)
5013-8 (3008733)
Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
12480-0 (3009991)
12480-0 (3009991)
Leukocytes [#/volume] in Cerebral spinal fluid
26465-5 (3016543)
26465-5 (3016543)
Bacteria identified in Cerebral spinal fluid by Culture
606-4 (3016914)
606-4 (3016914)
Appearance of Cerebral spinal fluid
10333-3 (3023410)
10333-3 (3023410)
Albumin [Mass/volume] in Cerebral spinal fluid
1746-7 (3024474)
1746-7 (3024474)
Erythrocytes [#/volume] in Cerebral spinal fluid
26454-9 (3027475)
26454-9 (3027475)
Cerebrospinal fluid IgG ratio and IgG index
1324000 (4027681)
1324000 (4027681)
Vertebro-basilar artery syndrome
G45.0 (45538120)
G45.0 (45538120)
Occlusion and stenosis of carotid artery
I65.2 (45552808)
I65.2 (45552808)
Hemiplegia, unspecified
G81.9 (45562106)
G81.9 (45562106)
Vestibular neuronitis
H81.2 (45562323)
H81.2 (45562323)
Carotid artery syndrome (hemispheric)
G45.1 (45576586)
G45.1 (45576586)
Other and ill-defined cerebrovascular disease, Without mention of hypertension
43899 (2000302686)
43899 (2000302686)
Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE,TYYPPI II]
2500A (2000402294)
2500A (2000402294)
Essential hypertension, Unspecified
4019X (2000403546)
4019X (2000403546)
Other and ill-defined cerebrovascular disease, Other generalised ischaemic cerebrovascular disease
4371A (2000403748)
4371A (2000403748)
Non-insulin dependent diabetes diabetic hypoglycaemic coma
E11.00 (2000501437)
E11.00 (2000501437)
Familial hypercholesterolaemia
E78.00 (2000501513)
E78.00 (2000501513)
Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms
F00.10*G30.1 (2000501573)
F00.10*G30.1 (2000501573)
Complex partial epileptic seizure with secondary generalization
G40.22 (2000502141)
G40.22 (2000502141)
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
G40.29 (2000502142)
G40.29 (2000502142)
Headache
R51.80 (2000503603)
R51.80 (2000503603)
Short MRI examination of brain with median intensity magnet
AA1AG (2001300107)
AA1AG (2001300107)
Standard MRI examination of brain with high intensity magnet
AA1BG (2001300112)
AA1BG (2001300112)
MRI examination of brain with 3 Tesla magnet
AA1BM (2001300113)
AA1BM (2001300113)
Extensive MRI examination of brain with high intensity magnet
AA1CG (2001300116)
AA1CG (2001300116)
CT examination of brain pefusion
AA5PD (2001300195)
AA5PD (2001300195)
CT angiography of brain
PA2AD (2001300223)
PA2AD (2001300223)
CT angiography of neck and brain
PA7BD (2001300235)
PA7BD (2001300235)
Intravascular evacuation of brain artery embolus
PA2VT (2001300365)
PA2VT (2001300365)
Lumbar puncture
TAB00 (2001300538)
TAB00 (2001300538)
Other intraoperative electrophysiological investigation in arhythmia or disturbance of impulse propagation
XFP96 (2001303143)
XFP96 (2001303143)
Standard cardiac ultrasound examination
FM1AE (2001303278)
FM1AE (2001303278)
Doppler ultrasound examination of heart
FM1DE (2001303299)
FM1DE (2001303299)
Ambulatory ECG
XF404 (2001303370)
XF404 (2001303370)
X-ray examination of the lungs in one projection
GD1PA (2001303645)
GD1PA (2001303645)
Thorax X-ray examination outside radiological department
GD1UA (2001303652)
GD1UA (2001303652)
Catheterisation of bladder
TKC20 (2001306020)
TKC20 (2001306020)
CT of neck arteries
PA6AD (2001308692)
PA6AD (2001308692)
Extensive CT of neck arteries
PA6BD (2001308697)
PA6BD (2001308697)
Extensive MRI examination of neck vasculature with high intensity magnet
PA6CG (2001308703)
PA6CG (2001308703)
Neck artery ultrasound examination with Doppler method
PA6DE (2001308705)
PA6DE (2001308705)
Cathetrisation of artery
TPH07 (2001309747)
TPH07 (2001309747)
Evaluation of communicative skills
R1260 (2001310179)
R1260 (2001310179)
Physiotherapy
R4110 (2001310233)
R4110 (2001310233)
Occupational therapy
R4120 (2001310234)
R4120 (2001310234)
Speech therapy
R4130 (2001310235)
R4130 (2001310235)
Monitored bed care
WX892 (2001310850)
WX892 (2001310850)
Body CT examination
JN4AD (2001310897)
JN4AD (2001310897)
Medical doctor
Z2221 (2001311556)
Z2221 (2001311556)
Social worker
Z2446 (2001311559)
Z2446 (2001311559)
Physiotherapist
Z3226 (2001311560)
Z3226 (2001311560)
Cerebrovascular disease
K91 (2002000618)
K91 (2002000618)
isosorbide dinitrate; local oral, oral, sublingual, transdermal
C01DA08 (21600321)
C01DA08 (21600321)
colecalciferol; oral
A11CC05 (21600820)
A11CC05 (21600820)
quetiapine; oral
N05AH04 (21604544)
N05AH04 (21604544)
Gas panel - Venous blood
24339-4 (3000991)
24339-4 (3000991)
ABO and Rh group [Type] in Blood
882-1 (3003694)
882-1 (3003694)
Creatine kinase.MB [Mass/volume] in Serum or Plasma
13969-1 (3005785)
13969-1 (3005785)
Methemoglobin/Hemoglobin.total in Arterial blood
2615-3 (3006217)
2615-3 (3006217)
Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
24386-5 (3006441)
24386-5 (3006441)
Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
2157-6 (3007220)
2157-6 (3007220)
Borrelia burgdorferi IgM Ab [Units/volume] in Serum
7818-8 (3008230)
7818-8 (3008230)
Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
3181-5 (3009041)
3181-5 (3009041)
Carboxyhemoglobin/Hemoglobin.total in Venous blood
2032-1 (3010517)
2032-1 (3010517)
Magnesium [Moles/volume] in Serum or Plasma
2601-3 (3012095)
2601-3 (3012095)
Fractional oxyhemoglobin in Arterial blood
2714-4 (3014007)
2714-4 (3014007)
Lactate [Moles/volume] in Serum or Plasma
2524-7 (3014111)
2524-7 (3014111)
Differential panel - Cerebral spinal fluid
29584-0 (3016018)
29584-0 (3016018)
Borrelia burgdorferi IgG Ab [Units/volume] in Serum
7817-0 (3016888)
7817-0 (3016888)
Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
21598-8 (3016894)
21598-8 (3016894)
Specific gravity of Urine by Refractometry
5810-7 (3019150)
5810-7 (3019150)
Protein [Mass/volume] in Cerebral spinal fluid
2880-3 (3019473)
2880-3 (3019473)
Glucose [Moles/volume] in Cerebral spinal fluid
14744-7 (3020044)
14744-7 (3020044)
Body temperature
8310-5 (3020891)
8310-5 (3020891)
Methemoglobin/Hemoglobin.total in Venous blood
2617-9 (3024889)
2617-9 (3024889)
Carboxyhemoglobin/Hemoglobin.total in Arterial blood
2030-5 (3028653)
2030-5 (3028653)
Epithelial cells.squamous [#/volume] in Urine by Automated count
51486-9 (3029879)
51486-9 (3029879)
Epithelial cells.non-squamous [#/volume] in Urine by Automated count
51485-1 (3030306)
51485-1 (3030306)
Lactate [Moles/volume] in Cerebral spinal fluid
2520-5 (3035999)
2520-5 (3035999)
Thrombin time
3243-3 (3036489)
3243-3 (3036489)
Protein S actual/normal in Platelet poor plasma by Coagulation assay
27822-6 (3036669)
27822-6 (3036669)
Potassium [Moles/volume] in Arterial blood
32713-0 (3043409)
32713-0 (3043409)
Cell count panel - Cerebral spinal fluid
34563-7 (3044290)
34563-7 (3044290)
Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
44448-9 (3044355)
44448-9 (3044355)
aPTT.lupus sensitive actual/normal (normalized LA screen)
48022-8 (3048518)
48022-8 (3048518)
Clinical Cytogenetics and Genomics
OMOP4822000 (32411)
OMOP4822000 (32411)
Hearing and Speech Clinic/Center
261QH0700X (38004227)
261QH0700X (38004227)
Rehabilitation Hospital
283X00000X (38004285)
283X00000X (38004285)
Geriatric Medicine
38 (38004478)
38 (38004478)
Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
56764-4 (40759883)
56764-4 (40759883)
Cells panel - Urine sediment
58434-2 (40761535)
58434-2 (40761535)
Sequelae of cerebral infarction
I69.3 (45533476)
I69.3 (45533476)
Hyperlipidaemia, unspecified
E78.5 (45537986)
E78.5 (45537986)
Nausea and vomiting
R11 (45539317)
R11 (45539317)
Other amnesia
R41.3 (45539342)
R41.3 (45539342)
Transient cerebral ischaemic attack, unspecified
G45.9 (45542892)
G45.9 (45542892)
Cerebral infarction
I63 (45543186)
I63 (45543186)
Sequelae of cerebrovascular disease
I69 (45543192)
I69 (45543192)
Other vascular syndromes of brain in cerebrovascular diseases
G46.8 (45552536)
G46.8 (45552536)
Atherosclerotic cardiovascular disease, so described
I25.0 (45552783)
I25.0 (45552783)
Subjective visual disturbances
H53.1 (45557467)
H53.1 (45557467)
Visual field defects
H53.4 (45557469)
H53.4 (45557469)
Bacterial pneumonia, unspecified
J15.9 (45557621)
J15.9 (45557621)
Coma, unspecified
R40.2 (45558463)
R40.2 (45558463)
Unspecified dementia
F03 (45566772)
F03 (45566772)
Paraesthesia of skin
R20.2 (45568120)
R20.2 (45568120)
Depressive episode, unspecified
F32.9 (45571760)
F32.9 (45571760)
Bell palsy
G51.0 (45571815)
G51.0 (45571815)
Aortic (valve) insufficiency
I35.1 (45572087)
I35.1 (45572087)
Diplopia
H53.2 (45576792)
H53.2 (45576792)
Disorder of lipoprotein metabolism, unspecified
E78.9 (45581384)
E78.9 (45581384)
Tension-type headache
G44.2 (45581495)
G44.2 (45581495)
Paroxysmal atrial fibrillation
I48.0 (45581776)
I48.0 (45581776)
Concussion
S06.0 (45582805)
S06.0 (45582805)
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
R29.8 (45587505)
R29.8 (45587505)
Arteriovenous malformation of cerebral vessels
Q28.2 (45592370)
Q28.2 (45592370)
Other and unspecified abnormalities of gait and mobility
R26.8 (45597174)
R26.8 (45597174)
Other and unspecified convulsions
R56.8 (45602033)
R56.8 (45602033)
Orthostatic hypotension
I95.1 (45605872)
I95.1 (45605872)
Observation for suspected nervous system disorder
Z03.3 (45609903)
Z03.3 (45609903)
Emergency Room - Hospital
23 (8870)
23 (8870)
platelet aggregation inhibitors excl. heparin - combinations
B01AC30 (21601005)
B01AC30 (21601005)
acetylsalicylic acid, combinations excl. psycholeptics
N02BA51 (21604320)
N02BA51 (21604320)
clopidogrel; oral
B01AC04 (21600989)
B01AC04 (21600989)
Neurology
13 (38004458)
13 (38004458)
Inpatient Hospital
21 (8717)
21 (8717)
Prothrombin time (PT) actual/Normal
5894-1 (3033658)
5894-1 (3033658)
Emergency Room Visit
ER (9203)
ER (9203)
dipyridamole; oral, parenteral
B01AC07 (21600992)
B01AC07 (21600992)
acetylsalicylic acid; oral
B01AC06 (21600991)
B01AC06 (21600991)
Emergency Room and Inpatient Visit
ERIP (262)
ERIP (262)
Office Visit
OMOP4822458 (581477)
OMOP4822458 (581477)
Glucose [Moles/volume] in Serum or Plasma
14749-6 (3013826)
14749-6 (3013826)
General Practice
1 (38004446)
1 (38004446)
levetiracetam; oral, parenteral
N03AX14 (21604436)
N03AX14 (21604436)
Internal Medicine
11 (38004456)
11 (38004456)
aPTT in Platelet poor plasma by Coagulation assay
14979-9 (3018677)
14979-9 (3018677)
Outpatient Hospital
22 (8756)
22 (8756)
Emergency Medicine
93 (38004510)
93 (38004510)
Neurosurgery
14 (38004459)
14 (38004459)
Dizziness and giddiness
R42 (45568132)
R42 (45568132)
Paralysis/weakness
N18 (2002000729)
N18 (2002000729)
Essential (primary) hypertension
I10 (45591453)
I10 (45591453)
Other and unspecified symptoms and signs involving cognitive functions and awareness
R41.8 (45534452)
R41.8 (45534452)
Care involving use of other rehabilitation procedures
Z50.8 (45556842)
Z50.8 (45556842)
Leukocytes [#/volume] in Urine
30405-5 (3018095)
30405-5 (3018095)
C reactive protein [Mass/volume] in Serum or Plasma
1988-5 (3020460)
1988-5 (3020460)
Bacteria [#/volume] in Urine by Automated count
51480-2 (3031040)
51480-2 (3031040)
Epilepsy, unspecified
G40.9 (45562083)
G40.9 (45562083)
Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
3209-4 (3019250)
3209-4 (3019250)
Calcium.ionized [Moles/volume] in Serum or Plasma
1995-0 (3021347)
1995-0 (3021347)
Atrial fibrillation and flutter
I48 (45596206)
I48 (45596206)
Atherosclerosis of arteries of extremities
I70.2 (45538421)
I70.2 (45538421)
oxcarbazepine; oral
N03AF02 (21604418)
N03AF02 (21604418)
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
19072-8 (3016431)
19072-8 (3016431)
INR in Blood by Coagulation assay
34714-6 (3032080)
34714-6 (3032080)
pH of Serum or Plasma
2753-2 (3018418)
2753-2 (3018418)
Supine thorax X-ray examination
GD1QA (2001303648)
GD1QA (2001303648)
ECG with 12 standard connections
XF400 (2001303368)
XF400 (2001303368)
Gas panel - Arterial blood
24336-0 (3019060)
24336-0 (3019060)
Oxygen capacity [Volume Fraction] in Arterial blood
59275-8 (40762366)
59275-8 (40762366)
Hemoglobin [Mass/volume] in Arterial blood
30313-1 (3002173)
30313-1 (3002173)
General psychiatric examination, not elsewhere classified
Z00.4 (45605094)
Z00.4 (45605094)
Bicarbonate [Moles/volume] in Arterial blood
1960-4 (3008152)
1960-4 (3008152)
Atherosclerotic heart disease
I25.1 (45596196)
I25.1 (45596196)
Sodium [Moles/volume] in Serum or Plasma
2951-2 (3019550)
2951-2 (3019550)
Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
3216-9 (3020427)
3216-9 (3020427)
MCHC [Entitic Mass/volume] in Red Blood Cells
28540-3 (3003338)
28540-3 (3003338)
Neutrophil cytoplasmic Ab [Units/volume] in Serum
5128-4 (3001334)
5128-4 (3001334)
Potassium [Moles/volume] in Serum or Plasma
2823-3 (3023103)
2823-3 (3023103)
Carbon dioxide [Partial pressure] in Arterial blood
2019-8 (3027946)
2019-8 (3027946)
pH of Arterial blood
2744-1 (3019977)
2744-1 (3019977)
Oxygen [Partial pressure] in Arterial blood
2703-7 (3027801)
2703-7 (3027801)
Base excess in Arterial blood by calculation
1925-7 (3003396)
1925-7 (3003396)
pH of Urine
2756-5 (3015736)
2756-5 (3015736)
Lupus anticoagulant assay
63300003 (4268621)
63300003 (4268621)
Type 2 diabetes mellitus, without complications
E11.9 (45561952)
E11.9 (45561952)
Oxygen saturation in Arterial blood
2708-6 (3016502)
2708-6 (3016502)
Supplier / Service Provider
OMOP5117446 (33004)
OMOP5117446 (33004)
Albumin [Mass/volume] in Serum or Plasma
1751-7 (3024561)
1751-7 (3024561)
Bicarbonate [Moles/volume] standard in Arterial blood
19230-2 (3014218)
19230-2 (3014218)
Psychiatry
26 (38004469)
26 (38004469)
Albumin [Presence] in Urine by Test strip
50949-7 (3029937)
50949-7 (3029937)
Erythrocyte [DistWidth] in Red Blood Cells
30385-9 (3002385)
30385-9 (3002385)
Urinalysis macro (dipstick) panel - Urine
24357-6 (3037467)
24357-6 (3037467)
Ketones [Presence] in Urine by Test strip
2514-8 (3035350)
2514-8 (3035350)
Occupational Medicine Clinic/Center
261QX0100X (38004267)
261QX0100X (38004267)
Glucose [Presence] in Urine by Test strip
25428-4 (3009261)
25428-4 (3009261)
Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method
4537-7 (3013707)
4537-7 (3013707)
CBC panel - Blood by Automated count
58410-2 (40761511)
58410-2 (40761511)
Nitrite [Presence] in Urine by Test strip
5802-4 (3021601)
5802-4 (3021601)
Proteinase 3 Ab [Units/volume] in Serum
6968-2 (3009445)
6968-2 (3009445)
Creatinine [Moles/volume] in Serum or Plasma
14682-9 (3020564)
14682-9 (3020564)
Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
54067-4 (3051552)
54067-4 (3051552)
12 lead EKG panel
34534-8 (3044889)
34534-8 (3044889)
Hemoglobin [Mass/volume] in Venous blood
30350-3 (3004119)
30350-3 (3004119)
Cardiology
6 (38004451)
6 (38004451)
Chloride [Moles/volume] in Serum or Plasma
2075-0 (3014576)
2075-0 (3014576)
Syncope and collapse
R55 (45568141)
R55 (45568141)
Alzheimer disease with late onset
G30.1 (45552521)
G30.1 (45552521)
Protein [Presence] in Urine by Test strip
20454-5 (3014051)
20454-5 (3014051)
Assessment of need for aid
SPAT1229 (2001700330)
SPAT1229 (2001700330)
Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
40987-0 (3043924)
40987-0 (3043924)
Epilepsy and comparable convulsive disorders
111 (2001600111)
111 (2001600111)
Troponin I.cardiac [Mass/volume] in Serum or Plasma
10839-9 (3021337)
10839-9 (3021337)
Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
40982-1 (3038288)
40982-1 (3038288)
Hematocrit [Volume Fraction] of Blood by calculation
20570-8 (3009542)
20570-8 (3009542)
MCH [Entitic mass]
28539-5 (3035941)
28539-5 (3035941)
Erythrocytes [#/volume] in Blood
26453-1 (3026361)
26453-1 (3026361)
MCV [Entitic mean volume] in Red Blood Cells
30428-7 (3024731)
30428-7 (3024731)
Platelets [#/volume] in Blood
26515-7 (3007461)
26515-7 (3007461)
Hemoglobin [Mass/volume] in Blood
718-7 (3000963)
718-7 (3000963)
Leukocytes [#/volume] in Blood
26464-8 (3010813)
26464-8 (3010813)
Chronic hypertension
205 (2001600203)
205 (2001600203)
Complement C3 [Mass/volume] in Serum or Plasma
4485-9 (3000620)
4485-9 (3000620)
Asthma, unspecified
J45.9 (45562456)
J45.9 (45562456)
Respiratory and circulatory monitoring
WX700 (2001310817)
WX700 (2001310817)
Oxygen [Partial pressure] in Venous blood
2705-2 (3024354)
2705-2 (3024354)
Otolaryngology
4 (38004449)
4 (38004449)
Complement C4 [Mass/volume] in Serum or Plasma
4498-2 (3017766)
4498-2 (3017766)
Benign paroxysmal vertigo
H81.1 (45572061)
H81.1 (45572061)
Cholesterol in HDL [Moles/volume] in Serum or Plasma
14646-4 (3023602)
14646-4 (3023602)
Triglyceride [Moles/volume] in Serum or Plasma --fasting
47210-0 (3048773)
47210-0 (3048773)
Short blood count panel - Blood
55429-5 (40758558)
55429-5 (40758558)
Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
2874-6 (3023465)
2874-6 (3023465)
Cholesterol [Moles/volume] in Serum or Plasma
14647-2 (3019900)
14647-2 (3019900)
Heart failure, unspecified
I50.9 (45576879)
I50.9 (45576879)
Cholesterol in LDL [Moles/volume] in Serum or Plasma
22748-8 (3001308)
22748-8 (3001308)
Thyrotropin [Units/volume] in Serum or Plasma
3016-3 (3009201)
3016-3 (3009201)
Sleep apnoea
G47.3 (45562094)
G47.3 (45562094)
Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
35559-4 (3035797)
35559-4 (3035797)
Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
50796-2 (3029338)
50796-2 (3029338)
Moderate depressive episode without somatic syndrome
F32.10 (2000501980)
F32.10 (2000501980)
Outpatient Visit
OP (9202)
OP (9202)
Base excess in Venous blood by calculation
1927-3 (3002032)
1927-3 (3002032)
Care involving use of rehabilitation procedure, unspecified
Z50.9 (45595525)
Z50.9 (45595525)
Carbon dioxide [Partial pressure] in Venous blood
2021-4 (3021447)
2021-4 (3021447)
Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
51435-6 (3029713)
51435-6 (3029713)
Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M
62238-1 (40764999)
62238-1 (40764999)
Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
32730-4 (3043723)
32730-4 (3043723)
Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
32731-2 (3043747)
32731-2 (3043747)
Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
2868-8 (3005229)
2868-8 (3005229)
Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
2865-4 (3015322)
2865-4 (3015322)
Hemoglobin A1c/Hemoglobin.total in Blood
4548-4 (3004410)
4548-4 (3004410)
pH of Venous blood
2746-6 (3012544)
2746-6 (3012544)
Malaise and fatigue
R53 (45553741)
R53 (45553741)
Speech disorder
N19 (2002000730)
N19 (2002000730)
Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
19258-3 (3004529)
19258-3 (3004529)
Bicarbonate [Moles/volume] in Venous blood
14627-4 (3027273)
14627-4 (3027273)
Normoblasts [#/volume] in Blood
715-3 (3021589)
715-3 (3021589)
Weakness/tiredness general
A04 (2002000145)
A04 (2002000145)
Anesthesiology Critical Care Medicine
OMOP4821991 (45756751)
OMOP4821991 (45756751)
Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
34487-9 (3044938)
34487-9 (3044938)
Assessment of adjustments needed in living environment
SPAT1231 (2001700332)
SPAT1231 (2001700332)
Sodium and Potassium panel [Moles/volume] - Serum or Plasma
34548-8 (3045783)
34548-8 (3045783)
Protein [Mass/volume] in Serum or Plasma
2885-2 (3020630)
2885-2 (3020630)
carbamazepine; oral, rectal
N03AF01 (21604417)
N03AF01 (21604417)
Bilirubin.total [Moles/volume] in Serum or Plasma
14631-6 (3006140)
14631-6 (3006140)
Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1742-6 (3006923)
1742-6 (3006923)
Inpatient Visit
IP (9201)
IP (9201)
Vascular dementia, unspecified
F01.9 (45533058)
F01.9 (45533058)
valproic acid; oral, parenteral, rectal
N03AG01 (21604422)
N03AG01 (21604422)
atorvastatin; oral
C10AA05 (21601860)
C10AA05 (21601860)
Epilepsy
G40 (45595935)
G40 (45595935)
Implementation of occupational therapy rehabilitation plan
SPAT1226 (2001700327)
SPAT1226 (2001700327)
Laboratory Visit
OMOP4822461 (32036)
OMOP4822461 (32036)
Type 2 diabetes mellitus, with unspecified complications
E11.8 (45561951)
E11.8 (45561951)
Pure hypercholesterolaemia
E78.01 (2000501514)
E78.01 (2000501514)
Assessment of need for services (elderly/care support)
SPAT1217 (2001700318)
SPAT1217 (2001700318)
Protein electrophoresis panel - Serum or Plasma
24351-9 (3004588)
24351-9 (3004588)
Type 2 diabetes mellitus, with multiple complications
E11.7 (45561950)
E11.7 (45561950)
Nuclear Ab [Titer] in Serum
29953-7 (3037522)
29953-7 (3037522)
General Surgery
2 (38004447)
2 (38004447)
Vertigo/dizziness
N17 (2002000728)
N17 (2002000728)
Monocytes [#/volume] in Blood
26484-6 (3001604)
26484-6 (3001604)
Basophils [#/volume] in Blood
26444-0 (3006315)
26444-0 (3006315)
Calcium [Moles/volume] in Serum or Plasma
2000-8 (3015377)
2000-8 (3015377)
Other diagnostic examination of periferal vessel
XPX99 (2001309755)
XPX99 (2001309755)
Physical Medicine And Rehabilitation
25 (38004468)
25 (38004468)
Other specified special examinations
Z01.8 (45581003)
Z01.8 (45581003)
Bacteria identified in Blood by Culture
600-7 (3023368)
600-7 (3023368)
Extractable nuclear Ab [Units/volume] in Serum
30342-0 (3015171)
30342-0 (3015171)
Troponin T.cardiac [Mass/volume] in Serum or Plasma
6598-7 (3019800)
6598-7 (3019800)
Eosinophils [#/volume] in Blood
26449-9 (3013115)
26449-9 (3013115)
Differential panel, method unspecified - Blood
69738-3 (42870588)
69738-3 (42870588)
Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
27811-9 (3000515)
27811-9 (3000515)
Functional capacity evaluation
443351003 (40481051)
443351003 (40481051)
Cathetrisation of vein
TPH04 (2001309597)
TPH04 (2001309597)
Cortisol [Moles/volume] in Serum or Plasma
14675-3 (3036481)
14675-3 (3036481)
Lymphocytes [#/volume] in Blood
26474-7 (3019198)
26474-7 (3019198)
Neutrophils [#/volume] in Blood by Automated count
751-8 (3013650)
751-8 (3013650)
Examination and observation for other specified reasons
Z04.8 (45552063)
Z04.8 (45552063)
Fasting glucose [Moles/volume] in Serum or Plasma
14771-0 (3018251)
14771-0 (3018251)
Other specified urinary incontinence
N39.4 (45577525)
N39.4 (45577525)
rosuvastatin; oral
C10AA07 (21601862)
C10AA07 (21601862)
Intravenous
ZX120 (2001311495)
ZX120 (2001311495)
Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1920-8 (3013721)
1920-8 (3013721)
Basophils/Leukocytes in Blood
30180-4 (3022096)
30180-4 (3022096)
Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
6768-6 (3035995)
6768-6 (3035995)
Eosinophils/Leukocytes in Blood
26450-7 (3006504)
26450-7 (3006504)
Monocytes/Leukocytes in Blood
26485-3 (3019069)
26485-3 (3019069)
Bacteria identified in Urine by Culture
630-4 (3026008)
630-4 (3026008)
Bacteria [Presence] in Urine
87829-8 (36304419)
87829-8 (36304419)
baclofen; oral, parenteral
M03BX01 (21604115)
M03BX01 (21604115)
Pain in limb
M79.6 (45587063)
M79.6 (45587063)
Lymphocytes/Leukocytes in Blood
26478-8 (3002030)
26478-8 (3002030)
Thyroxine (T4) free [Moles/volume] in Serum or Plasma
14920-3 (3008486)
14920-3 (3008486)
Neutrophils/Leukocytes in Blood
26511-6 (3018010)
26511-6 (3018010)
Casts [#/volume] in Urine by Automated count
51483-6 (3030467)
51483-6 (3030467)
IgG [Mass/volume] in Serum or Plasma
2465-3 (3005719)
2465-3 (3005719)
Folate [Moles/volume] in Red Blood Cells
14731-4 (3019309)
14731-4 (3019309)
Ophthalmology
18 (38004463)
18 (38004463)
Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
48065-7 (3051714)
48065-7 (3051714)
Urinalysis microscopic panel [#/volume] - Urine by Automated count
50554-5 (3029287)
50554-5 (3029287)
clonazepam; oral, parenteral
N03AE01 (21604415)
N03AE01 (21604415)
Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
2742-5 (3034780)
2742-5 (3034780)
Folate [Moles/volume] in Serum or Plasma
14732-2 (3021960)
14732-2 (3021960)
Aid fitting and borrowing and monitoring of use
SPAT1230 (2001700331)
SPAT1230 (2001700331)
Fall on same level from slipping, tripping and stumbling
W01 (45756243)
W01 (45756243)
Hemoglobin [Presence] in Urine by Test strip
5794-3 (3011397)
5794-3 (3011397)
Calcium [Moles/volume] corrected for albumin in Serum or Plasma
29265-6 (3020059)
29265-6 (3020059)
insulin (human); parenteral
A10AB01 (21600715)
A10AB01 (21600715)
Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
2324-2 (3026910)
2324-2 (3026910)
gabapentin; oral
N02BF01 (955005)
N02BF01 (955005)
Implementation of physical therapy rehabilitation plan
SPAT1223 (2001700324)
SPAT1223 (2001700324)
citalopram; oral, parenteral
N06AB04 (21604712)
N06AB04 (21604712)
Examination of eyes and vision
Z01.0 (45566391)
Z01.0 (45566391)
duloxetine; oral
N06AX21 (21604749)
N06AX21 (21604749)
Perimetry
XCK00 (2001301380)
XCK00 (2001301380)
Erythrocytes [#/volume] in Urine
30391-7 (3002582)
30391-7 (3002582)
acetylsalicylic acid; oral, parenteral, rectal
N02BA01 (21604305)
N02BA01 (21604305)
Holo-transcobalamin II [Moles/volume] in Serum
72160-5 (43054903)
72160-5 (43054903)
potassium chloride; oral
A12BA01 (21600877)
A12BA01 (21600877)
dabigatran etexilate; oral
B01AE07 (21601026)
B01AE07 (21601026)
nifedipine; oral, parenteral
C08CA05 (21601751)
C08CA05 (21601751)
Phosphate [Moles/volume] in Serum or Plasma
14879-1 (3003458)
14879-1 (3003458)
Case Management Agency
251B00000X (38004193)
251B00000X (38004193)
Orthopedic Surgery
20 (38004465)
20 (38004465)
enoxaparin; parenteral
B01AB05 (21600976)
B01AB05 (21600976)
mirtazapine; oral
N06AX11 (21604740)
N06AX11 (21604740)
Urgent procedure
ZXD05 (2001311386)
ZXD05 (2001311386)
Urea [Moles/volume] in Serum or Plasma
22664-7 (3020779)
22664-7 (3020779)
Home Visit
OMOP4822459 (581476)
OMOP4822459 (581476)
Neuropsychological evaluation of need and possibilities to rehabilitation
R1230 (2001310176)
R1230 (2001310176)
ABO and Rh group [Type] in Blood by Confirmatory method
77397-8 (46236098)
77397-8 (46236098)
Nursing episode
950 (44777714)
950 (44777714)
Acute tubulo-interstitial nephritis
N10 (45543856)
N10 (45543856)
ramipril; oral
C09AA05 (21601789)
C09AA05 (21601789)
Osmolality of Urine
2695-5 (3026782)
2695-5 (3026782)
candesartan; oral
C09CA06 (21601829)
C09CA06 (21601829)
More than one and less than three hours
ZXE10 (2001311401)
ZXE10 (2001311401)
Telehealth
OMOP5556618 (722455)
OMOP5556618 (722455)
Other specified chronic obstructive pulmonary disease
J44.8 (45586673)
J44.8 (45586673)
Thorax X-ray examination
GD1AA (2001303617)
GD1AA (2001303617)
Vascular Surgery
77 (38004496)
77 (38004496)
amlodipine; oral
C08CA01 (21601747)
C08CA01 (21601747)
Pneumonia, unspecified
J18.9 (45601123)
J18.9 (45601123)
Iron/Transferrin [Ratio] in Serum or Plasma
60517-0 (40763571)
60517-0 (40763571)
Iron [Moles/volume] in Serum or Plasma
14798-3 (3022948)
14798-3 (3022948)
Blood type and Crossmatch panel - Blood
34531-4 (3044640)
34531-4 (3044640)
Transferrin [Mass/volume] in Serum or Plasma
3034-6 (3004789)
3034-6 (3004789)
Limited function/disability NOS
A28 (2002000162)
A28 (2002000162)
Amylase [Enzymatic activity/volume] in Serum or Plasma
1798-8 (3016771)
1798-8 (3016771)
insulin (human); parenteral
A10AD01 (21600729)
A10AD01 (21600729)
Counselling/guidance promoting independent living
SPAT1222 (2001700323)
SPAT1222 (2001700323)
Triglyceride [Moles/volume] in Serum or Plasma
14927-8 (3025839)
14927-8 (3025839)
Chronic ischaemic heart disease, unspecified
I25.9 (45552784)
I25.9 (45552784)
escitalopram; oral
N06AB10 (21604718)
N06AB10 (21604718)
Blood group antibody screen [Presence] in Serum or Plasma
890-4 (3001079)
890-4 (3001079)
warfarin; oral, parenteral
B01AA03 (21600965)
B01AA03 (21600965)
Other specified counselling
Z71.8 (45581061)
Z71.8 (45581061)
Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
30248-9 (3015399)
30248-9 (3015399)
Person consulting for explanation of investigation findings
Z71.2 (45552100)
Z71.2 (45552100)
amitriptyline; oral, parenteral
N06AA09 (21604696)
N06AA09 (21604696)
Pharmacy visit
OMOP4822462 (581458)
OMOP4822462 (581458)
Limited function/disability (L)
L28 (2002000647)
L28 (2002000647)
Epithelial cells [#/volume] in Urine
30383-4 (3000850)
30383-4 (3000850)
Memory disturbance
P20 (2002000816)
P20 (2002000816)
Chest pain, unspecified
R07.4 (45558450)
R07.4 (45558450)
ezetimibe; oral
C10AX09 (21601896)
C10AX09 (21601896)
Leukocyte esterase [Presence] in Urine by Automated test strip
60026-2 (40763086)
60026-2 (40763086)
Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M
77147-7 (46236952)
77147-7 (46236952)
pregabalin; oral
N02BF02 (955152)
N02BF02 (955152)
metoclopramide; oral, parenteral, rectal
A03FA01 (21600484)
A03FA01 (21600484)
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
351 (2001600312)
351 (2001600312)
paracetamol; oral, parenteral, rectal
N02BE01 (21604344)
N02BE01 (21604344)
25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
68438-1 (40771025)
68438-1 (40771025)
Extensive structural and functional ultrasound examination of heart
FM1EE (2001303307)
FM1EE (2001303307)
simvastatin; oral
C10AA01 (21601856)
C10AA01 (21601856)
Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
33762-6 (3029187)
33762-6 (3029187)
SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
94500-6 (706163)
94500-6 (706163)
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
290 (2001600222)
290 (2001600222)
No procedures
SPAT1301 (2001700402)
SPAT1301 (2001700402)
Erythrocytes [Presence] in Urine by Automated
53292-9 (3041096)
53292-9 (3041096)
oxycodone; oral, parenteral
N02AA05 (21604260)
N02AA05 (21604260)
One hour or less
ZXE00 (2001311394)
ZXE00 (2001311394)
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
47598-8 (3048816)
47598-8 (3048816)
pantoprazole; oral, parenteral
A02BC02 (21600097)
A02BC02 (21600097)
Memory test
SPAT1053 (2001700154)
SPAT1053 (2001700154)
Chronic arrhythmias
207 (2001600205)
207 (2001600205)
Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
13317-3 (3019902)
13317-3 (3019902)
codeine and paracetamol
N02AJ06 (1123647)
N02AJ06 (1123647)
tramadol; oral, parenteral, rectal
N02AX02 (21604298)
N02AX02 (21604298)
bisoprolol; oral
C07AB07 (21601689)
C07AB07 (21601689)
Clinical & Laboratory Dermatological Immunology Physician
207NI0002X (38003841)
207NI0002X (38003841)
FEV1/FVC
19926-5 (3011505)
19926-5 (3011505)
Forced vital capacity [Volume] Respiratory system
19870-5 (3020158)
19870-5 (3020158)
FEV1
20150-9 (3024653)
20150-9 (3024653)
Forced vital capacity [Volume] Respiratory system --post bronchodilation
19875-4 (3001668)
19875-4 (3001668)
FEV1 --post bronchodilation
20155-8 (3023550)
20155-8 (3023550)
FEV1/FVC --post bronchodilation
69970-2 (42868459)
69970-2 (42868459)
FVC percent change Respiratory system
69982-7 (42868471)
69982-7 (42868471)
FEV1 percent change
69983-5 (42868472)
69983-5 (42868472)
prednisolone
A07EA01 (21600653)
A07EA01 (21600653)
prednisolone; oral, parenteral
H02AB06 (21602734)
H02AB06 (21602734)
losartan; oral
C09CA01 (21601824)
C09CA01 (21601824)
cefalexin; oral
J01DB01 (21602870)
J01DB01 (21602870)
CBC W Ordered Manual Differential panel - Blood
57782-5 (40760892)
57782-5 (40760892)
EKG study
11524-6 (3013512)
11524-6 (3013512)
Treatment-related counselling outside office
SPAT1249 (2001700350)
SPAT1249 (2001700350)
furosemide; oral, parenteral
C03CA01 (21601518)
C03CA01 (21601518)
LabWAS
↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
966
3470
3.60
216.42
2.1
1.9
29.25
29.96
s
3.20
934
3339
1497
7536
2.93
181.97
2.9
2.1
203.12
243.19
u/l
0.67
1435
7024
190
420
4.75
79.95
1.4
1.3
41.54
46.53
e6/l
0.05
132
316
190
425
4.69
78.79
1.5
1.4
1270.54
545.63
e6/l
0.63
136
334
190
443
4.50
74.78
1.3
1.3
3.73
3.74
mmol/l
0.05
180
411
203
502
4.25
74.04
1.5
1.3
505.18
619.76
mg/l
2.57
194
471
1756
12696
1.89
62.85
25.2
18.5
1.42
1.35
inr
4.57
1498
10693
524
2495
2.32
60.29
2.9
2.4
4.98
6.99
ug/l
2.03
460
2153
984
5985
1.95
59.10
4.7
4.1
84.03
85.02
%
0.53
963
5847
631
3284
2.16
58.22
7.2
6.9
5.06
5.10
kpa
0.45
603
3138
630
3282
2.15
57.96
7.2
6.9
11.87
11.81
kpa
0.11
602
3139
1955
14906
1.86
56.17
6.6
5.0
6.92
6.86
mmol/l
0.63
1888
14157
620
3272
2.12
54.84
7.2
6.9
1.19
1.05
mmol/l
0.38
492
2646
106
224
4.86
46.95
1.3
1.2
1.66
2.65
u/ml
0.70
32
80
553
2953
2.06
46.69
7.5
7.1
95.15
95.19
%
0.03
531
2844
612
3450
1.96
44.11
2.1
1.8
—
—
—
0
0
98
211
4.76
42.45
1.3
1.2
5.65
4.13
u/ml
0.41
40
98
506
2702
2.04
42.38
7.9
7.6
118.71
119.46
g/l
0.34
492
2634
632
3679
1.90
41.07
2.1
1.8
—
—
—
0
0
823
5261
1.77
39.15
5.1
4.1
212.16
643.96
ng/l
1.75
708
4505
366
1786
2.19
38.64
7.0
6.3
24.70
24.50
mmol/l
0.41
350
1707
463
2472
2.02
38.53
3.3
2.9
4.58
4.39
kpa
1.05
451
2398
527
2961
1.94
37.81
4.0
3.4
5.90
5.81
kpa
1.09
514
2872
465
2507
2.00
37.59
6.9
6.6
1.37
1.38
mmol/l
0.04
456
2448
1575
12051
1.63
37.26
5.5
4.8
34.59
34.83
g/l
0.88
1475
11206
824
5338
1.74
37.08
1.8
1.8
1167.38
1169.84
nmol/l
0.03
653
3964
511
2866
1.94
36.77
4.4
3.5
1.80
1.80
mmol/l
0.01
454
2454
89
207
4.39
35.06
1.1
1.1
—
—
—
0
0
1567
12118
1.60
34.36
7.7
6.4
1.20
1.21
mmol/l
5.76
1489
11105
150
506
3.06
34.04
2.4
2.5
195.86
206.09
%
0.71
145
477
1714
13596
1.59
33.27
8.8
7.2
1.20
1.21
mmol/l
4.31
1548
11646
757
4955
1.70
32.07
2.2
1.9
—
—
—
0
0
54
90
6.08
31.01
1.3
1.1
0.56
0.50
ratio
0.69
31
52
847
5807
1.63
29.59
6.1
4.5
1.03
1.27
kg/l
0.46
606
3972
59
113
5.29
29.28
1.3
1.1
—
—
—
0
0
64
133
4.88
28.95
1.3
1.1
36.46
43.53
mg/l
0.87
57
113
1984
16551
1.56
28.74
6.8
5.2
321.32
2827.01
e6/l
3.73
28
285
348
1858
1.98
28.50
3.4
3.0
127.96
127.00
g/l
0.34
341
1807
1535
12129
1.53
28.39
2.5
2.2
92.39
94.22
pmol/l
0.83
869
6397
1341
10293
1.53
28.38
5.8
4.3
41.62
95.38
ng/l
2.02
1079
7995
301
1546
2.05
27.44
3.1
2.5
0.66
0.62
%
1.47
301
1537
61
128
4.83
27.29
1.2
1.0
287.44
291.73
mg/l
0.05
55
111
92
271
3.46
26.08
4.0
5.2
343.18
341.55
umol/l
0.04
85
243
57
119
4.85
25.67
1.2
1.0
—
—
—
0
0
331
1801
1.94
25.54
9.1
8.5
93.64
93.69
%
0.05
331
1790
74
193
3.90
25.08
1.5
1.2
—
—
—
0
0
1149
8766
1.49
23.74
4.3
3.5
58.57
87.07
e6/l
1.22
917
6829
1006
7520
1.50
22.72
4.1
3.4
0.52
0.47
e6/l
0.29
779
5656
354
2047
1.82
22.49
1.8
1.6
—
—
—
0
0
1242
9719
1.46
22.12
5.1
4.1
140.67
120.71
e6/l
0.16
921
7085
1593
13072
1.45
22.06
5.5
4.2
0.00
4.86
estimate
2.44
289
2891
63
162
3.94
21.80
1.1
1.0
—
—
—
0
0
548
3605
1.63
21.74
6.5
5.5
1.04
1.05
mmol/l
0.09
515
3327
642
4393
1.58
21.60
3.1
3.0
0.82
0.82
mmol/l
0.36
606
4091
1597
13160
1.44
21.31
5.5
4.2
0.04
0.12
estimate
0.32
267
2699
673
4670
1.56
21.26
3.5
3.1
1.75
1.11
e6/l
0.97
375
2567
265
1421
1.94
21.25
3.5
3.3
25.46
25.16
mmol/l
0.79
257
1365
784
5641
1.52
20.94
3.2
3.1
2.46
2.46
mmol/l
0.59
706
5040
44
88
5.05
20.85
1.5
1.2
—
—
—
0
0
286
1583
1.89
20.83
5.1
3.5
24.23
24.04
mmol/l
0.43
281
1560
2062
17870
1.47
20.72
35.6
24.2
330.45
331.25
g/l
3.49
2050
17729
1495
12215
1.43
20.63
6.3
5.9
0.63
0.62
e9/l
1.52
1279
10279
1404
11342
1.44
20.61
3.3
2.9
—
—
estimate
—
0
0
1499
12259
1.43
20.55
6.4
6.0
0.04
0.04
e9/l
0.70
1285
10328
46
97
4.79
20.51
1.0
1.0
1.56
1.27
u/l
0.38
18
49
194
943
2.12
20.39
4.3
3.5
1.28
1.42
mmol/l
1.35
189
925
282
1566
1.88
20.32
9.3
9.5
15.73
15.76
%
0.07
271
1507
1068
8222
1.46
20.21
1.9
1.7
19.02
19.98
nmol/l
1.21
952
6875
986
7490
1.46
19.95
2.8
2.4
2.99
2.96
mg/l
0.15
865
6389
1556
12870
1.42
19.69
5.5
4.2
0.00
0.00
estimate
0.80
277
2799
246
1338
1.91
18.87
4.8
5.0
1.59
1.55
%
0.27
231
1266
123
511
2.46
18.74
1.8
2.6
27.58
35.20
umol/l
3.66
106
453
288
1652
1.82
18.68
9.0
8.4
24.18
24.27
mmol/l
0.17
277
1604
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
46
105
4.42
18.64
1.2
1.1
—
—
—
0
0
1509
12486
1.41
18.64
6.4
6.0
1.88
1.86
e9/l
0.08
1317
10789
1166
9242
1.42
18.35
3.3
3.5
2.34
2.35
mmol/l
1.55
1056
8315
410
2618
1.65
18.07
6.9
6.3
10.74
11.60
mmol/l
1.20
394
2485
38
76
5.04
18.03
1.2
1.1
1.05
1.07
ratio
0.52
33
59
828
6196
1.46
17.70
3.3
2.7
5.08
5.39
e6/l
0.34
764
5634
1514
12612
1.39
17.56
6.6
6.2
0.20
0.20
e9/l
0.23
1318
10797
1649
13990
1.38
16.82
3.5
3.2
51.79
54.73
u/l
0.51
1550
12793
606
4310
1.50
16.59
3.7
3.3
2.82
2.20
e6/l
0.81
307
2199
224
1234
1.88
16.50
5.0
5.1
0.84
0.87
%
0.48
209
1163
391
2532
1.62
16.21
3.3
3.1
238.35
251.25
ng/l
0.22
367
2313
707
5208
1.46
16.18
2.1
1.6
1.55
1.57
mg/l
0.03
555
4074
132
606
2.23
16.04
2.4
2.3
3.63
3.65
g/l
0.04
127
577
663
4831
1.47
16.03
3.0
2.6
11.00
12.14
umol/l
4.42
615
4449
1628
13859
1.37
15.83
9.2
9.3
4.55
4.30
e9/l
3.53
1420
11907
125
568
2.25
15.58
6.1
6.9
105.63
105.11
mmol/l
0.69
112
507
125
568
2.25
15.58
6.1
6.9
11.16
11.33
mmol/l
0.22
112
507
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
178
927
1.97
15.52
3.2
2.5
0.36
0.33
iu/ml
0.62
102
495
808
6170
1.42
15.04
2.9
2.5
—
—
—
0
0
122
560
2.22
14.85
1.4
1.3
—
—
—
0
0
122
560
2.22
14.85
1.4
1.3
—
—
—
0
0
51
150
3.43
14.61
1.2
1.2
2.01
2.16
mmol/l
0.54
45
138
1586
13547
1.35
14.56
6.1
6.4
11.44
12.34
umol/l
1.87
1518
12902
1990
17602
1.37
14.54
5.0
4.4
14.44
14.14
mm/h
0.34
1882
16196
455
3139
1.52
14.21
12.0
8.0
—
—
—
0
0
388
2611
1.55
13.55
2.3
2.7
65.83
65.97
g/l
0.14
358
2372
233
1379
1.74
13.53
2.5
2.5
15.91
22.88
au/ml
0.95
16
113
216
1255
1.77
13.38
1.4
1.3
42.86
55.82
au/ml
—
10
95
1957
17371
1.35
13.30
4.6
4.3
15.08
15.06
pmol/l
0.17
1793
15600
40
108
3.73
13.03
1.7
2.1
—
—
—
0
0
1150
9519
1.33
12.36
3.7
3.3
1877.86
1821.64
ng/l
0.14
1020
8307
567
4199
1.43
12.21
3.1
2.6
19.64
21.76
%
3.83
530
3864
926
7440
1.35
12.13
6.0
4.3
0.00
0.00
estimate
1.54
252
2502
2092
18887
1.33
11.86
8.7
8.2
81.78
81.81
u/l
0.01
1993
17819
603
4539
1.41
11.80
3.1
2.6
2.26
2.26
g/l
0.11
562
4158
29
67
4.35
11.65
1.1
1.1
—
—
—
0
0
168
949
1.81
11.45
2.3
2.1
327.98
755.45
ug/l
1.19
163
898
994
8170
1.32
10.87
2.9
2.6
62.37
70.36
u/l
0.32
932
7519
300
2006
1.55
10.71
2.8
2.9
60.96
59.82
ml/min/173m2
0.19
134
913
1156
9724
1.30
10.59
5.8
4.3
0.03
0.28
estimate
0.59
226
2305
132
709
1.90
10.57
3.7
3.4
2.04
1.95
index
0.05
68
359
1273
10862
1.29
10.40
3.7
3.1
124.81
147.66
ug/l
3.96
1185
9932
27
65
4.17
10.31
2.3
2.4
50.19
47.16
umol/l
0.16
21
52
2432
22611
1.36
10.30
27.1
18.3
27.87
27.64
mg/l
0.12
2160
19051
161
942
1.74
9.78
1.4
1.2
—
—
—
0
0
31
88
3.54
9.46
1.2
1.1
28.14
258.79
ng/l
—
7
24
1331
11549
1.27
9.09
6.5
6.3
25.29
26.08
%
1.92
1247
10855
808
6593
1.30
8.99
3.7
3.3
0.05
0.05
0.01
22
238
328
2318
1.46
8.95
2.7
2.4
36.41
40.02
u/l
0.41
285
1929
1301
11290
1.26
8.77
6.4
6.1
59.09
58.59
%
0.79
1238
10694
1275
11064
1.26
8.52
2.7
2.4
76.59
79.44
nmol/l
3.27
1146
9758
44
166
2.67
8.34
1.1
1.0
271.50
311.69
ng/l
0.71
30
108
112
618
1.84
8.32
1.2
1.2
—
—
—
0
0
44
167
2.65
8.25
1.1
1.0
36.28
41.77
ng/l
0.53
30
107
44
167
2.65
8.25
1.1
1.0
761.90
695.39
ng/l
0.34
31
104
112
621
1.83
8.20
1.2
1.2
—
—
—
0
0
1975
18063
1.26
8.13
32.4
22.8
14.06
13.88
%
5.99
1956
17795
303
2148
1.45
8.13
2.1
2.2
376.22
383.84
nmol/l
0.28
265
1965
210
3091
0.65
8.03
6.0
5.1
34.39
33.03
%
0.93
145
1901
2245
20868
1.28
7.96
6.1
5.4
1.91
2.03
mu/l
4.14
2098
18876
61
281
2.19
7.53
1.2
1.2
0.18
0.20
nmol/l
0.77
47
233
900
7583
1.26
7.52
3.3
3.1
31.55
36.44
u/l
1.86
847
7106
152
944
1.64
7.46
1.5
1.9
39.80
39.30
u/l
0.10
128
828
25
73
3.44
7.36
2.4
2.7
31.13
29.58
umol/l
0.30
16
49
67
326
2.07
7.21
1.3
1.3
0.58
6.11
nmol/l
0.51
67
312
1316
11605
1.23
7.19
2.9
2.6
—
—
—
0
0
380
2866
1.37
7.13
2.1
2.5
68.77
67.40
e9/l
0.36
272
2135
144
893
1.64
7.12
2.0
1.7
36.08
6.51
iu/ml
0.51
43
199
259
1844
1.44
6.80
2.0
1.7
—
—
—
0
0
67
336
2.01
6.68
1.3
1.3
0.26
0.29
nmol/l
—
7
18
298
2186
1.40
6.62
4.4
3.7
104.64
95.45
ng/l
0.83
266
1859
22
64
3.45
6.54
1.1
1.1
—
—
—
0
0
17
41
4.16
6.52
1.4
1.2
—
—
—
0
0
190
1284
1.51
6.50
2.2
1.9
1.98
2.26
ug/l
0.13
168
1135
32
119
2.70
6.31
1.4
1.2
149.06
142.25
nmol/l
0.23
32
119
24
76
3.17
6.26
1.5
1.1
—
—
—
0
0
131
821
1.62
6.25
1.2
1.2
0.29
0.79
u/ml
0.85
18
61
2278
21419
1.24
6.17
8.3
7.1
41.76
40.19
mmol/mol
10.64
2160
19643
30
110
2.74
6.09
1.2
1.1
—
—
—
0
0
361
2797
1.33
5.66
2.3
2.6
7.58
9.42
umol/l
0.95
311
2484
1176
10435
1.20
5.60
13.5
12.4
0.01
0.00
e9/l
0.29
941
8455
212
1513
1.43
5.53
1.5
1.7
1.57
1.54
g/l
0.15
190
1294
15
28
5.37
5.52
11.4
13.7
5.47
5.71
mmol/l
0.19
15
28
2190
20591
1.22
5.50
5.1
4.4
1.31
1.27
mmol/l
1.65
2040
18349
1022
8979
1.20
5.35
4.2
4.2
10.53
8.42
mg/mmol
0.70
688
5665
781
6686
1.22
5.33
3.1
2.9
358.74
358.35
umol/l
0.03
665
5755
20
63
3.18
5.29
1.5
1.4
45.64
31.68
%
0.68
14
41
2463
23474
1.24
5.25
33.3
22.4
139.53
139.57
mmol/l
0.37
2436
22943
2465
23505
1.24
5.17
33.4
22.7
4.00
4.01
mmol/l
0.18
2432
22937
19
59
3.23
5.15
1.1
1.1
—
—
—
0
0
49
246
2.00
4.96
4.2
3.4
14.82
11.07
index
0.97
28
128
19
61
3.12
4.89
1.1
1.1
—
—
—
0
0
33
142
2.33
4.89
1.3
1.4
1.21
1.04
promille
0.24
25
112
693
5908
1.22
4.88
1.9
1.8
9475905.63
24415148.23
pmol/l
0.72
591
4784
478
3935
1.25
4.66
1.3
1.3
39.69
35.98
iu/ml
0.11
136
1192
1011
8977
1.19
4.54
3.6
3.4
7.13
7.17
mmol/l
0.11
873
7476
129
872
1.50
4.50
1.3
1.3
—
—
—
0
0
43
214
2.02
4.49
1.3
1.7
—
1268.57
—
0
7
10
15
6.67
4.46
1.1
1.5
—
—
—
0
0
54
292
1.86
4.44
1.7
1.4
—
—
—
0
0
560
4714
1.23
4.43
1.3
1.3
2.16
1.45
u/ml
0.49
147
1209
57
314
1.83
4.42
2.7
3.2
9.52
10.47
mmol/l
1.33
57
309
178
1291
1.40
4.30
2.8
3.4
4.17
4.42
pmol/l
3.23
162
1128
421
3447
1.25
4.29
3.7
4.0
230.65
250.01
u/l
3.99
397
3246
103
673
1.55
4.23
1.3
1.5
0.23
19.56
iu/ml
0.90
30
129
27
116
2.33
4.06
1.1
1.1
—
—
—
0
0
155
1109
1.42
4.06
2.3
2.5
9.14
10.32
g/l
2.38
139
991
88
562
1.58
4.01
1.8
1.5
—
—
—
0
0
48
260
1.86
3.96
1.8
1.6
—
—
—
0
0
230
1762
1.33
3.94
2.7
3.0
10.26
10.73
g/l
0.72
212
1609
44
235
1.88
3.80
1.7
1.6
40.60
24.50
u/ml
0.87
15
40
23
95
2.43
3.78
2.0
2.6
66.31
103.98
umol/l
1.06
13
64
17
60
2.84
3.77
1.2
1.1
—
—
—
0
0
53
302
1.76
3.73
1.3
1.3
314.17
300.23
pmol/l
0.09
48
256
23
96
2.40
3.70
4.9
1.7
71.47
63.86
mg/l
0.23
15
66
38
195
1.96
3.70
1.6
1.3
—
—
—
0
0
28
128
2.19
3.68
4.7
3.4
0.75
0.89
index
0.46
28
128
17
61
2.79
3.67
1.1
1.1
—
—
—
0
0
97
1412
0.68
3.59
2.0
2.1
3.40
3.46
ratio
0.18
79
1139
38
198
1.93
3.55
1.6
1.3
—
—
—
0
0
100
678
1.49
3.52
1.6
1.6
—
—
—
0
0
66
1034
0.63
3.48
1.7
1.8
3.02
3.44
mmol/l
1.85
49
763
11
27
4.08
3.38
1.1
1.2
32.50
67.13
%
—
6
8
87
578
1.52
3.38
1.4
1.4
—
—
—
0
0
76
491
1.56
3.35
1.4
1.3
—
—
—
0
0
8
14
5.72
3.33
1.0
2.5
—
—
—
0
0
42
232
1.82
3.31
1.0
1.2
—
—
—
0
0
249
1980
1.28
3.28
1.9
1.7
1.54
1.52
%
0.15
227
1677
171
1292
1.34
3.27
2.2
2.4
7.38
7.45
g/l
0.22
155
1185
74
479
1.56
3.25
1.3
1.3
140.00
380.41
titre
—
6
49
170
1289
1.33
3.18
2.2
2.4
3.60
3.74
g/l
0.59
154
1183
58
357
1.63
3.14
14.4
6.2
7.98
7.26
mmol/l
0.87
48
296
170
1292
1.33
3.14
2.2
2.4
4.18
4.15
g/l
0.18
154
1187
236
1882
1.27
3.05
1.6
1.4
—
—
—
0
0
53
323
1.65
3.00
1.7
1.5
—
—
—
0
0
69
449
1.55
2.99
1.2
1.2
29.00
54.68
u/ml
—
7
46
9
21
4.29
2.98
1.0
1.2
—
—
—
0
0
9
21
4.29
2.98
1.0
1.1
—
—
—
0
0
483
4161
1.19
2.97
1.4
1.5
2.47
2.60
g/l
0.75
273
2451
158
1200
1.33
2.95
2.3
2.5
2.92
2.94
g/l
0.12
142
1094
21
94
2.24
2.95
1.1
1.3
141.80
169.50
mmol/24h
1.18
21
94
57
356
1.61
2.94
5.9
6.2
11.51
12.62
mg/l
1.12
52
328
32
169
1.90
2.93
2.2
2.0
—
—
—
0
0
120
876
1.38
2.89
2.1
2.5
0.00
0.00
g/l
-0.00
111
770
42
243
1.73
2.88
1.9
1.6
—
—
—
0
0
311
2577
1.23
2.88
2.1
2.2
142.82
144.55
ug/g
0.03
263
2035
20
89
2.25
2.85
1.1
1.1
—
—
—
0
0
2478
23970
1.17
2.85
34.7
24.8
86.35
83.49
umol/l
2.41
2454
23588
27
136
1.99
2.83
1.1
1.1
3.69
11.48
nmol/l
—
5
26
18
77
2.34
2.80
1.2
1.1
1864.28
1560.19
miu/ml
0.48
18
77
100
712
1.42
2.79
1.7
1.5
—
—
—
0
0
46
276
1.67
2.78
1.7
1.5
55.50
62.41
%
0.58
32
172
17
72
2.36
2.71
3.5
2.1
0.63
0.61
mmol/l
0.33
17
72
102
738
1.39
2.62
1.8
1.5
0.22
0.31
mg/l
1.51
46
316
13
49
2.65
2.61
1.2
1.8
—
—
—
0
0
309
2592
1.21
2.55
2.0
2.1
0.21
0.20
g/l
0.76
284
2406
42
253
1.67
2.53
1.5
1.3
103665.81
75063.90
e6/l
0.11
26
173
10
31
3.23
2.51
1.1
1.0
—
—
—
0
0
10
31
3.23
2.51
1.1
1.1
—
—
—
0
0
19
88
2.16
2.49
1.1
1.1
—
—
—
0
0
144
1113
1.31
2.43
2.2
2.5
0.98
1.14
g/l
0.18
128
949
2302
22230
1.14
2.39
7.3
6.1
2.27
2.59
mmol/l
58.70
2183
20150
25
131
1.91
2.39
1.5
1.5
62.53
67.96
%
0.25
17
106
9
27
3.33
2.38
1.1
1.2
—
—
—
0
0
2232
21520
1.13
2.35
6.0
5.2
1.37
1.45
mmol/l
17.31
2101
19428
103
763
1.36
2.33
1.3
1.3
—
—
—
0
0
106
789
1.35
2.32
3.9
3.3
1.53
1.67
mmol/l
1.40
106
766
136
1050
1.31
2.32
2.8
2.7
—
—
—
0
0
97
713
1.37
2.30
2.6
2.2
128.49
127.46
g/l
0.15
80
556
73
511
1.44
2.29
1.4
1.4
—
—
—
0
0
106
791
1.35
2.29
3.3
3.3
0.84
0.83
nmol/l
0.12
88
629
21
105
2.00
2.29
1.5
1.9
95.57
100.18
%
0.26
21
100
56
373
1.51
2.26
2.5
2.5
4.11
4.11
mmol/l
0.00
56
368
56
373
1.51
2.26
2.5
2.5
105.02
105.61
mmol/l
0.48
56
368
50
325
1.54
2.25
1.5
1.4
183.94
152.59
au/ml
1.56
17
92
77
548
1.41
2.22
1.3
1.2
—
—
—
0
0
55
368
1.50
2.18
2.5
2.5
1.21
1.19
mmol/l
1.34
55
363
24
129
1.86
2.15
1.1
1.2
88.00
86.29
—
5
7
2428
23575
1.14
2.14
15.0
12.6
26.26
24.72
u/l
0.77
2362
22687
9
30
3.00
2.14
1.1
1.0
—
—
—
0
0
417
3654
1.16
2.10
1.3
1.3
13.58
12.29
u/ml
0.12
149
1280
21
110
1.91
2.04
1.0
1.1
—
—
—
0
0
20
103
1.94
2.04
1.3
1.4
3.27
3.30
mmol/l
0.02
20
95
88
653
1.36
2.01
2.3
2.2
111.76
104.37
ug/min
0.05
48
366
8
26
3.08
2.01
1.1
1.2
—
—
—
0
0
70
503
1.40
1.95
1.3
1.3
27.50
30.70
iu/l
0.37
56
427
8
27
2.96
1.93
1.3
1.2
—
—
—
0
0
19
99
1.92
1.89
1.4
1.3
—
—
—
0
0
7
22
3.18
1.87
1.0
1.0
—
—
—
0
0
39
254
1.54
1.80
2.7
2.7
—
—
—
0
0
102
791
1.30
1.76
1.5
1.4
251.00
272.49
ug/g
0.53
72
482
2482
24209
1.12
1.76
39.5
27.8
91.55
91.72
fl
1.03
2463
23806
2482
24211
1.12
1.75
40.4
28.4
39.12
39.57
%
3.75
2463
23796
2482
24211
1.12
1.75
39.5
27.9
4.34
4.39
e12/l
4.75
2441
23463
2482
24214
1.12
1.73
39.5
28.0
7.22
6.89
e9/l
5.49
2441
23460
2482
24215
1.12
1.73
39.8
28.1
130.41
132.59
g/l
9.89
2462
23824
2481
24207
1.12
1.72
39.6
27.9
243.00
241.72
e9/l
0.41
2448
23560
2238
21717
1.11
1.71
6.2
5.2
4.11
4.49
mmol/l
57.54
2122
19751
11
48
2.29
1.69
2.7
2.0
—
—
—
0
0
831
7705
1.10
1.68
4.8
5.0
22.94
22.15
%
0.69
396
4151
17
90
1.89
1.64
2.2
8.5
63.58
74.81
%
0.57
12
73
48
335
1.44
1.62
1.4
1.4
6.75
6.29
mmol/l
0.54
48
314
43
294
1.47
1.61
1.3
1.3
279.70
274.17
mosm/kgh2o
0.89
33
210
11
50
2.20
1.56
2.7
2.0
—
—
—
0
0
35
231
1.52
1.55
1.9
1.5
—
—
—
0
0
35
231
1.52
1.55
1.9
1.5
—
—
—
0
0
35
231
1.52
1.55
1.9
1.5
—
—
—
0
0
974
9141
1.09
1.51
2.0
1.9
1.36
1.31
mmol/l
0.58
862
7522
2254
21928
1.10
1.51
6.1
5.6
6.21
6.06
mmol/l
4.61
2078
19646
87
677
1.29
1.50
4.1
3.4
7.75
7.73
mmol/l
0.02
87
657
94
740
1.28
1.49
1.6
1.7
—
—
—
0
0
23
139
1.66
1.47
1.2
1.2
—
—
—
0
0
5
16
3.12
1.43
1.0
1.3
10.00
16.88
u/l
—
5
16
6
22
2.72
1.43
2.2
1.9
—
—
—
0
0
13
66
1.97
1.42
1.2
1.3
—
—
—
0
0
86
675
1.28
1.41
1.7
1.6
15793.85
17090.40
e6/l
0.08
62
476
23
141
1.63
1.40
2.9
2.0
—
—
—
0
0
23
141
1.63
1.40
1.2
1.2
—
—
—
0
0
90
712
1.27
1.39
1.5
1.4
—
—
—
0
0
22
134
1.64
1.38
1.5
1.7
315.69
296.79
mu/l
0.18
16
107
56
416
1.35
1.36
1.7
1.8
—
—
—
0
0
12
61
1.97
1.32
3.1
2.0
30.00
26.19
%
0.40
12
53
24
152
1.58
1.30
1.1
1.4
—
—
—
0
0
24
152
1.58
1.30
1.1
1.4
—
—
—
0
0
67
516
1.30
1.29
1.7
1.8
—
—
—
0
0
297
2641
1.14
1.28
1.7
1.4
—
—
—
0
0
88
704
1.25
1.26
1.7
1.5
—
—
—
0
0
29
194
1.50
1.25
1.5
2.2
8.74
8.14
mmol/l
0.32
29
194
41
294
1.40
1.25
1.1
1.1
—
—
—
0
0
32
220
1.46
1.22
1.6
1.5
27.81
25.84
%
0.14
23
137
22
140
1.57
1.19
2.8
1.9
19.68
17.48
%
0.29
22
132
18
110
1.64
1.14
3.8
7.0
3.46
179.37
ug/l
0.61
11
72
523
5611
0.92
1.08
3.0
3.5
0.79
0.83
ug/l
0.32
360
3973
47
610
0.77
1.04
1.4
1.7
4.32
5.08
mg/l
0.23
41
464
63
499
1.27
1.03
1.5
1.4
—
—
—
0
0
115
971
1.19
1.02
1.1
1.0
—
—
—
0
0
24
345
0.69
1.01
2.2
2.3
15.50
22.05
mg/l
—
6
122
14
83
1.69
1.00
1.1
1.1
—
—
—
0
0
53
412
1.29
1.00
1.6
1.8
4.69
4.69
mmol/24h
0.00
48
358
9
49
1.84
0.98
41.2
8.3
7.04
4.94
kpa
—
9
49
37
491
0.75
0.97
1.6
1.4
—
—
—
0
0
71
576
1.24
0.96
1.7
1.9
2.26
4.15
iu/l
3.67
26
233
6
27
2.22
0.93
1.7
1.9
22.73
15.98
umol/l
—
6
27
9
52
1.73
0.92
1.1
1.5
1.18
1.16
mmol/l
—
9
52
19
126
1.51
0.90
1.2
1.5
—
—
—
0
0
11
63
1.75
0.89
1.4
1.8
79.77
625.11
nmol/24h
0.64
11
63
76
627
1.21
0.89
1.6
1.5
—
—
—
0
0
6
29
2.07
0.89
1.0
1.1
—
—
—
0
0
10
168
0.59
0.87
2.3
3.8
—
—
—
0
0
17
111
1.53
0.87
1.1
1.2
—
—
—
0
0
145
1270
1.15
0.85
1.3
1.3
162.20
230.48
u/ml
1.11
125
1184
42
325
1.29
0.85
1.3
1.2
261.84
287.10
u/ml
0.22
25
174
62
504
1.23
0.85
1.4
1.5
29.41
31.09
g/l
0.51
56
461
11
65
1.69
0.81
1.3
1.2
1.38
1.51
mmol/l
—
6
43
336
3098
1.09
0.81
3.5
4.1
23.00
21.66
ug/l
0.03
284
2568
0
24
0.00
0.79
0.0
1.0
—
—
—
0
0
47
374
1.26
0.78
1.2
1.5
—
—
—
0
0
53
428
1.24
0.78
1.4
1.4
—
—
—
0
0
56
456
1.23
0.77
6.0
4.9
523.00
3929.79
iu/ml
0.47
11
62
54
438
1.23
0.77
1.4
1.4
853.42
3750.06
e6/l
0.84
36
308
21
148
1.42
0.77
2.7
2.3
—
—
—
0
0
44
349
1.26
0.76
1.3
1.2
—
143.96
—
0
5
49
603
0.81
0.76
3.5
3.6
29.91
29.44
mg/l
0.03
36
438
22
157
1.40
0.75
1.3
1.1
—
—
—
0
0
21
149
1.41
0.74
1.3
1.1
—
—
—
0
0
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
9
54
1.67
0.74
1.2
1.2
98.67
106.27
%
—
9
49
18
254
0.71
0.73
1.3
1.1
—
73.86
—
0
14
9
56
1.61
0.72
2.3
1.3
—
—
—
0
0
88
755
1.17
0.71
1.5
1.6
30.34
21.66
u/ml
0.38
11
140
74
626
1.18
0.71
1.3
1.2
7.03
7.89
u/ml
0.10
12
94
9
58
1.55
0.69
1.0
1.1
—
—
—
0
0
36
283
1.27
0.68
2.3
1.9
5049.89
4567.38
u/l
—
8
105
21
152
1.38
0.68
1.3
1.1
—
—
—
0
0
9
59
1.52
0.68
1.1
1.1
—
—
—
0
0
139
1242
1.12
0.65
2.1
2.1
0.00
0.72
estimate
0.50
57
349
23
172
1.34
0.63
3.2
5.2
282.70
43.71
u/ml
—
6
55
73
626
1.17
0.62
1.3
1.2
46.70
3.30
u/ml
—
5
55
32
401
0.79
0.61
1.2
1.1
0.55
0.67
ratio
—
6
57
5
30
1.66
0.61
1.2
1.0
48.60
41.99
iu/ml
—
5
30
64
544
1.18
0.61
1.4
1.2
27.18
37.01
u/l
0.58
58
462
18
130
1.38
0.60
1.3
1.3
—
—
—
0
0
18
130
1.38
0.60
1.3
1.3
—
—
—
0
0
9
138
0.65
0.60
1.0
1.7
38.49
39.47
g/l
—
9
138
21
157
1.34
0.58
1.3
1.1
—
—
—
0
0
12
173
0.69
0.58
1.1
1.0
—
—
—
0
0
303
2834
1.07
0.56
4.0
3.7
—
—
—
0
0
8
124
0.64
0.54
2.0
1.6
—
—
—
0
0
31
248
1.25
0.54
1.1
1.1
—
4.17
—
0
31
14
193
0.72
0.54
1.6
1.4
—
—
—
0
0
12
82
1.46
0.54
1.0
1.2
—
—
—
0
0
90
1012
0.88
0.53
4.8
4.0
24.67
24.84
mmol/l
0.20
81
922
128
1156
1.11
0.53
3.0
3.4
396.85
105.10
mg/l
0.45
115
995
128
1156
1.11
0.53
3.0
3.4
29.36
67.35
mg/l
2.09
116
998
15
108
1.39
0.52
1.2
1.2
—
—
—
0
0
44
368
1.20
0.52
1.4
1.5
—
—
—
0
0
46
388
1.19
0.50
1.5
1.4
108682.57
81295.10
e6/l
0.13
23
222
11
75
1.47
0.50
1.1
1.1
—
—
—
0
0
10
67
1.49
0.49
1.2
1.4
—
2190609.80
—
0
5
70
613
1.14
0.49
2.7
3.3
4035.42
1106.73
u/ml
0.41
63
557
120
1087
1.11
0.48
2.5
3.2
4893.79
1843.02
u/ml
0.36
99
934
31
375
0.82
0.47
1.1
1.1
—
—
—
0
0
5
83
0.60
0.45
1.0
1.3
—
—
—
0
0
5
85
0.59
0.45
1.8
1.5
95.79
52.57
ug/l
—
5
85
42
356
1.18
0.45
2.8
2.6
140.00
1558.55
u/ml
—
5
31
21
166
1.26
0.42
1.3
1.1
—
—
—
0
0
113
1030
1.10
0.42
2.9
3.3
11.49
5.30
ratio
0.33
68
626
702
6792
1.04
0.41
4.8
3.7
0.06
0.16
estimate
0.36
215
2166
8
58
1.38
0.41
5.8
2.0
1.37
2.44
ratio
—
8
52
13
96
1.35
0.41
3.0
2.4
5.14
4.78
kpa
0.79
13
96
13
96
1.35
0.41
3.0
2.4
9.29
10.04
kpa
0.47
13
96
8
59
1.35
0.40
1.0
2.4
320.38
542.75
ug/l
—
8
59
8
60
1.33
0.40
1.3
1.1
—
—
—
0
0
7
101
0.69
0.39
2.6
1.7
—
—
—
0
0
0
19
0.00
0.39
0.0
1.1
—
—
—
0
0
0
19
0.00
0.39
0.0
1.0
—
—
—
0
0
13
170
0.76
0.38
1.7
1.5
—
—
—
0
0
19
233
0.81
0.35
1.4
1.3
—
—
—
0
0
38
436
0.87
0.34
1.2
1.2
1.49
1.55
g/l
0.58
38
436
17
135
1.26
0.34
3.4
2.2
31.50
124.45
ug/min
—
8
33
15
188
0.80
0.33
1.3
1.5
—
—
—
0
0
6
46
1.30
0.33
1.0
1.3
—
—
—
0
0
13
165
0.79
0.32
1.7
1.5
—
—
—
0
0
35
303
1.15
0.32
4.8
3.7
—
—
—
0
0
23
192
1.20
0.31
1.3
1.2
—
—
—
0
0
7
52
1.34
0.31
2.1
1.6
163.91
113.49
ug/l
—
7
47
7
98
0.71
0.30
1.7
1.2
5.47
6.29
mmol/l
—
7
93
54
485
1.11
0.30
2.0
1.6
—
—
—
0
0
21
175
1.20
0.29
2.2
2.4
17.75
43.32
iu/ml
—
6
28
21
175
1.20
0.29
1.3
1.5
0.38
0.31
nmol/l
0.18
13
137
45
401
1.12
0.28
1.3
1.3
10.73
10.02
u/l
0.17
33
323
99
1059
0.93
0.27
2.0
1.8
—
—
—
0
0
178
1861
0.95
0.25
2.8
2.2
12.45
12.54
nmol/l
0.04
157
1628
148
1402
1.06
0.25
1.9
2.0
1.10
1.45
g/l
1.93
141
1261
29
254
1.14
0.24
1.1
1.2
52.41
61.40
u/l
0.78
24
229
26
226
1.15
0.24
2.3
1.7
4.55
4.64
mg/l
0.04
26
216
31
349
0.89
0.24
1.8
1.5
—
—
—
0
0
30
265
1.13
0.23
1.9
2.2
1.62
1.29
u/field
0.17
13
145
36
322
1.12
0.23
1.1
1.1
13.75
71.78
iu/ml
—
8
61
5
39
1.28
0.23
1.0
1.2
—
—
—
0
0
21
241
0.87
0.21
1.6
1.5
—
—
—
0
0
34
377
0.90
0.21
1.3
1.2
307.23
217.47
miu/ml
0.40
13
154
0
10
0.00
0.21
0.0
1.0
—
0.01
—
0
5
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
13
0.00
0.21
0.0
1.0
—
2.61
—
0
6
21
240
0.87
0.21
1.1
1.0
2.30
1.97
eliau/ml
—
9
82
80
749
1.07
0.20
1.3
1.6
—
—
—
0
0
217
2244
0.96
0.20
3.6
3.9
1.23
1.23
mmol/l
0.00
193
1903
0
14
0.00
0.20
0.0
1.9
—
28.00
—
0
14
24
211
1.14
0.20
2.3
2.1
724.89
627.89
ml
0.77
18
121
14
165
0.85
0.19
1.4
1.5
1.46
1.23
ratio
—
8
106
14
165
0.85
0.19
1.4
1.5
0.94
0.97
ratio
—
8
106
14
165
0.85
0.19
1.4
1.5
1.09
1.13
ratio
—
8
106
114
1082
1.05
0.19
2.2
1.8
—
—
—
0
0
198
1907
1.04
0.19
4.7
3.7
5.19
5.17
kpa
0.11
189
1811
14
164
0.85
0.18
1.4
1.5
—
—
—
0
0
170
1634
1.04
0.18
4.5
3.6
1.74
2.06
mmol/l
0.47
119
1201
38
348
1.09
0.17
2.3
2.2
5393.40
920.25
u/ml
0.39
38
342
55
587
0.93
0.17
1.3
1.2
—
—
—
0
0
37
340
1.09
0.16
1.6
1.3
—
—
—
0
0
143
1479
0.96
0.15
4.7
3.7
1.02
1.02
ratio
0.37
124
1355
21
188
1.12
0.14
1.5
1.9
94.16
123.20
ng/l
1.04
21
188
15
131
1.14
0.14
1.3
1.3
1.23
1.14
nmol/l
—
10
90
36
335
1.07
0.12
1.7
1.3
—
—
—
0
0
16
142
1.13
0.12
1.6
1.6
4.80
2.36
u/field
—
5
100
12
104
1.15
0.12
1.0
1.4
143.05
165.08
pmol/l
0.27
12
104
102
982
1.04
0.12
2.0
1.8
—
—
—
0
0
15
133
1.13
0.11
1.9
3.2
1.17
1.17
%
0.00
15
133
44
415
1.06
0.11
1.2
1.2
—
—
—
0
0
16
177
0.90
0.10
1.3
1.1
—
—
—
0
0
967
9573
1.01
0.10
5.3
6.2
2.77
4.15
ug/l
1.68
875
8525
36
338
1.06
0.10
1.7
1.3
—
—
—
0
0
12
135
0.89
0.10
3.7
1.5
—
—
—
0
0
12
135
0.89
0.10
3.7
1.5
—
—
—
0
0
12
135
0.89
0.10
3.7
1.5
—
—
—
0
0
12
135
0.89
0.10
3.7
1.5
—
—
—
0
0
5
45
1.11
0.09
1.0
1.1
—
—
—
0
0
17
154
1.10
0.09
1.4
1.5
9.44
6.69
u/l
0.34
12
130
5
47
1.06
0.09
1.2
1.4
—
—
—
0
0
111
1139
0.97
0.09
2.3
2.0
—
—
—
0
0
14
154
0.91
0.08
2.4
1.6
10.20
12.92
umol/l
—
5
102
7
65
1.07
0.08
2.6
1.3
11.09
8.92
ug/l
—
7
65
6
70
0.86
0.07
1.8
2.4
18.85
134.09
ug/l
—
6
63
37
387
0.95
0.07
2.5
1.9
18.09
25.12
ug/l
1.02
37
382
247
2434
1.01
0.06
1.4
1.4
—
—
—
0
0
34
327
1.04
0.04
1.7
1.3
—
—
—
0
0
26
271
0.96
0.04
1.2
1.1
2.21
1.46
u/ml
0.20
11
151
34
328
1.03
0.03
1.7
1.3
—
—
—
0
0
2157
21553
1.00
0.03
25.3
18.5
72.95
73.38
ml/min/173m2
0.40
2049
20112
34
329
1.03
0.03
1.7
1.3
—
—
—
0
0
19
197
0.96
0.01
1.2
1.1
0.42
1.11
u/ml
—
9
102
47
461
1.02
0.01
2.4
1.9
1.73
1.70
mmol/l
0.06
47
450
47
477
0.98
0.01
1.4
1.5
0.91
0.82
nmol/l
0.55
41
391
17
163
1.04
0.01
1.4
1.2
—
—
—
0
0
11
105
1.05
0.00
2.0
1.9
40.23
51.52
ug/l
0.75
11
100
21
214
0.98
0.00
1.2
1.2
102.29
101.92
pmol/l
0.01
21
214
10
96
1.04
0.00
4.2
1.6
—
—
—
0
0
10
96
1.04
0.00
4.2
1.6
—
—
—
0
0
21
211
0.99
0.00
1.8
1.5
—
—
—
0
0
15
155
0.97
0.00
1.3
1.6
78.93
86.66
umol/l
0.51
15
155
121
1207
1.00
0.00
1.2
1.2
83.79
135.83
u/ml
1.00
36
420
10
98
1.02
0.00
4.2
1.6
—
—
—
0
0
8
85
0.94
-0.00
1.6
1.4
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.3
—
2.44
—
0
9
0
6
0.00
-0.00
0.0
5.2
—
399.83
—
0
6
0
6
0.00
-0.00
0.0
1.2
—
7.57
—
0
6
0
8
0.00
-0.00
0.0
1.9
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
0.01
—
0
6
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint I9_CEREBDOTH and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| I9_CEREBDOTH | 1.804 [1.65, 1.98] | < 0.001 |
| Birth year | 0.993 [0.99, 1.0] | 0.089 |
During the follow-up period (1.1.1998 — 31.12.2019), 4689 out of 9333 females with I9_CEREBDOTH died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| I9_CEREBDOTH | 1.745 [1.58, 1.93] | < 0.001 |
| Birth year | 0.983 [0.97, 0.99] | < 0.001 |
During the follow-up period (1.1.1998 — 31.12.2019), 4617 out of 9686 males with I9_CEREBDOTH died.
Mortality risk
Mortality risk for people of age
years, who have I9_CEREBDOTH.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.154% | 0.319% |
| 5 | 0.957% | 1.904% |
| 10 | 2.44% | 4.433% |
| 15 | 4.835% | 8.401% |
| 20 | 8.489% | 14.215% |
Relationships between endpoints
↥Index endpoint: I9_CEREBDOTH – Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere
GWS hits: 1
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data